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The purpose of this study was to describe the quality of life in persons with end 
stage renal disease and examine factors that may affect quality of life.  A revised version 
of Wilson and Cleary’s model for health-related quality of life was used to guide the 
study.  Biological factors (serum albumin and serum hemoglobin), symptoms (dialysis 
symptoms, anxiety, depression, and fatigue), functional status, general health perception, 
characteristics of the individual (age, gender, race/ ethnicity), and characteristics of the 
environment (time on dialysis, marital status, and socioeconomic status) were examined 
to determine their potential impact on overall quality of life. 
A cross-sectional, correlational non-experimental study was conducted with a 
convenience sample of 73 persons undergoing hemodialysis at an outpatient dialysis 
center located within one city in central North Carolina.  The majority of the participants 
was female (55%), African American (76%), not married (67%), and had incomes above 
the federal poverty level (56%).  The mean age was 56 (SD = 15.8) and mean time on 
hemodialysis was 56 months (SD = 58.3).  When all variables were included in the 
model, 61% of the variability in overall quality of life was explained.  However, only the 
health-related variables of anxiety, depression, general health perception, and albumin 
significantly (p < .05) contributed to quality of life.  Quality of life may be better 
predicted from psychological factors than physiological factors.  Future studies should 
continue to identify factors that influence quality of life and determine interventions that 
enhance a person’s sense of well-being. 
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CHAPTER I 
 
BACKGROUND 
 
 
Introduction 
Approximately 20 million Americans have some degree of kidney damage 
(American Nephrology Nurses Association, 2007), and more than 470,000 people live 
with end stage renal disease (ESRD), the final stage of chronic kidney disease (U.S. 
Renal Data System [USRDS], 2006).  Each year more than 100,000 additional people are 
diagnosed with ESRD (USRDS, 2006).  Incidence of ESRD has dramatically increased 
over the past decade, increasing from 261.3 per million population in 1994 to 348.6 per 
million in 2004 (Centers for Disease Control and Prevention, 2007).  Because each 
person with ESRD uses approximately $58,000 in Medicare dollars each year (USRDS, 
2006), this increase in incidence of ESRD places a significant financial burden on the 
healthcare system.  Given these figures, it is imperative that persons with ESRD receive 
not only cost-effective care, but also care that contributes to an acceptable quality of life.  
However, the quality of life for persons with ESRD has been shown to be lower than the 
general public (Cleary & Drennan, 2005; DeOreo, 1997; Ferrans & Powers, 1993; Frank, 
Auslander, & Weissgarten, 2003; Merkus et al., 1999), and in many dialysis centers, “life 
at any cost” is the unspoken rule (Russ, Shim, & Kaufman, 2007).   
Quality of life for persons with ESRD is a growing concern among dialysis 
professionals for two reasons.  First, ensuring the highest acceptable quality of life 
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constitutes ethical care.  For years, determination of successful outcomes for persons with 
ESRD has been limited to clinically-focused measures of dialysis adequacy, such as 
acceptable laboratory values and inter-dialytic weight gain.  However, even when these 
physiological measures are met, the person on dialysis may not experience a satisfactory 
quality of life.  Therefore, other, more subjective, patient-focused measures are needed to 
augment the outcome evaluation for persons on dialysis.  Quality of life determination is 
one such measure. 
Second, quality of life measures may assist health care providers to track illness 
progression, including identification of the end of life.  Chronic illness progression for 
persons with ESRD has been described as having three phases:  crisis, chronic, and 
terminal (Jablonski, 2004).  The crisis phase begins with a diagnosis of ESRD and the 
initiation of dialysis.  The chronic phase is characterized by both stable and downward 
periods as the person undergoes multiple changes in condition which often necessitates 
short term hospitalization.  This chronic phase continues in a downward saw tooth pattern 
until it becomes apparent the person will not rebound.  This point is conceptualized as 
entering the terminal phase.  The terminal phase is often characterized by frequent 
hospitalizations as the patient undergoes progressive deterioration that ultimately ends in 
death. Identifying the transition from the chronic phase to the terminal phase is difficult.  
Currently, no research is available to guide this determination, although recent studies 
have shown that as quality of life decreases, death grows nearer (Kalantar-Zadeh, 
Kopple, Block, & Humphreys, 2001; Lopes et al., 2007).   
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Knowing when the terminal phase is near may assist with implementing end-of-
life interventions that can contribute to a good death (Kring, 2006).  Hospice services 
specifically designed for persons with ESRD could provide much needed assistance with 
regard to advanced care planning, decisions to stop dialysis, symptom management after 
dialysis withdrawal, and psychological support.  In addition to this ethical imperative, 
well planned, programmatic end-of-life care is also fiscally responsible.  Healthcare in 
the last year of life accounts for 27.4% of Medicare spending (Hogan, Lunney, Gabel, & 
Lynn, 2001), and averages $37, 581 per person (Hoover, Crystal, Kumar, Sambamoorthi, 
& Cantor, 2002).   Much of this cost is due to technology needed to maintain life, such as 
ventilators.  While using more healthcare resources at the end of life may be inevitable, 
futile healthcare is much more debatable; and unwanted, futile healthcare is simply 
immoral (Kring, 2007).  Identifying the quality of life in persons with ESRD may help 
clinicians understand and support their patients’ chronic illness progression, and noting 
significant declines may help identify the terminal phase, allowing for early end-of-life 
intervention.   
The first step in identifying quality of life in persons with ESRD is to understand 
what factors influence quality of life.  This information would provide a foundation to 
understand how quality of life can be used to identify phase transitions so that the chronic 
phase is managed with increased periods of stability, and to proactively assist persons 
with ESRD and their families to intentionally choose end-of-life experiences that are 
meaningful and spiritual, without unwanted, futile medical care.   
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Background and Significance 
For persons with ESRD, renal replacement therapy is crucial or death will quickly 
ensue.  Choices for renal replacement therapy include kidney transplantation, 
hemodialysis, or peritoneal dialysis.  Because of a lack of kidneys for transplantation, 
only about 17% of persons on the kidney transplant list in 2004 actually received a 
kidney (USRDS, 2006).  Thus, the majority of persons with ESRD require some type of 
dialysis to maintain life.  Of those on dialysis, 93% receive hemodialysis, and 7% receive 
peritoneal dialysis (USRDS, 2006).  Maintaining an acceptable quality of life for persons 
on hemodialysis can be challenging due to thrice weekly dialysis sessions, frequent 
surgical revisions of arterio-venous accesses, increased symptom burden, dietary 
restrictions, and complicated medication regimens. Therefore, quality of life is important 
to understand in this population for two reasons—to improve the quality of life, and to 
improve the quality of death.     
 Improving Quality of Life.  According to the World Health Organization, quality 
of life is “individuals’ perception of their position in life in the context of the culture and 
value systems in which they live and in relation to their goals, expectations, standards and 
concerns” (WHOQOL Group, 1998, p. 1570).  Knowing the quality of life, as well as 
factors that influence it, may assist clinicians in developing and implementing 
interventions targeted at improving it.  One intervention to enhance quality of life is 
palliative care. 
 Palliative care provides the patient with life enhancing (rather than life sustaining) 
interventions in an effort to improve quality of life.  Palliative care focuses on patients 
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whose disease is not responsive to curative treatment and includes control of pain, other 
symptoms, as well as psychological, social, and spiritual problems (World Health 
Organization, 1990).  The ultimate goal of palliative care is the best quality of life 
possible (Jablonski, 2007).  A common misconception of palliative care is that it is 
implemented during the end of life.  In fact, palliative care can be implemented at any 
point along the chronic illness trajectory and is compatible with active medical care.   
Indeed, the traditional model of palliative care did not allow for a palliative focus until 
curative care ceased (see Figure 1) (Jablonski, 2007).   
 The more modern integrated model of palliative care allows palliative care to be 
gradually incorporated as curative care becomes less effective.  Jablonski (2007) further 
suggests that persons with ESRD require a more aggressive palliative model in which life 
sustaining care (like dialysis) is provided with equal measure as comfort care during the 
entire illness continuum from diagnosis to death.  This holistic approach to care would 
allow persons with ESRD to benefit from the unique services of a dedicated palliative 
program that focuses on symptom management, advanced care planning, psychosocial 
and spiritual support, and assistance with decision-making near the end of life (Jablonski, 
2007).  Clearly, “active treatment and palliative care need not be mutually exclusive, 
especially in a disease that is at the same time chronic and life-limiting” (Jablonski, 2007, 
p.51).  Unfortunately, the integrated model of palliative care has yet to be specifically 
funded in the United States (U.S.) healthcare system because, currently, most palliative 
programs are administered in conjunction with hospices, requiring a terminal diagnosis to 
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begin services.  This arrangement leaves many persons with ESRD without access to 
palliative care until the end of life.   
 
 
Figure 1.  Models of palliative care. 
 
 
A. Traditional model of palliative care. 
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B.  Integrated model of palliative care. 
 
 
 
 
 
 
 
            Diagnosis             Death 
 
 
 
C.  Jablonski’s suggested model of palliative care for persons with ESRD. 
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 A subgroup of the Robert Wood Johnson Foundation’s program Promoting 
Excellence in End-of-Life Care examined ways to improve comfort and quality of life for 
persons with ESRD (End-Stage Renal Disease Workgroup, 2002).  They strongly 
recommended that palliative services be increased for this group through their local 
dialysis centers, with funding provided by the Centers for Medicare and Medicaid 
Services (CMS).  Some innovations in palliative care for persons with ESRD are already 
being developed.  For example, in Canada, a proposal is being considered to improve the 
quality of life in the dialysis population through a comprehensive palliative care program 
that would manage disease burden as well as avoid futile use of medical resources 
through deliberate advanced care planning (Fainsinger, Davison, & Brenneis, 2003).  In 
the U.S., the Renal Palliative Care Initiative was started as a collaboration between eight 
dialysis clinics and a medical center in western New England to integrate palliative 
medicine into nephrology medicine through education and collaboration with area 
hospices (Poppel, Cohen, & Germain, 2003).  Unfortunately, they are not getting 
reimbursed for these efforts and few dialysis centers are willing to take on the extra 
expense.  Both the Canadian and the U.S. initiatives demonstrate that a significant and 
targeted approach is needed to improve palliative services for this unique population.   
 Much work is still needed to determine the most effective palliative strategies for 
the ESRD population.  In a pilot study of a small group of hemodialysis patients, 
researchers found that a palliative care intervention did not improve quality of life, 
symptom burden, or completion of advance directives (Weisbord et al., 2003).  A 
significant barrier to success was the lack of follow through by nephrologists to 
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implement recommendations from the palliative care team.  Provider engagement in the 
palliative process is crucial, as many patients will not request these services on their own. 
Indeed, 63% of persons on hemodialysis have never spoken about care at the end of life 
with their nephrologist (Weisbord et al., 2003).  Nevertheless, targeted palliative services 
hold promise for improving the quality of life in this population. 
Other interventions that may improve quality of life include support and 
encouragement strategies, patient education, exercise programs, employment support, and 
active self-management (Curtin, Mapes, Petillo, & Oberley, 2002; Molzahn, 2006).  In 
addition, renal rehabilitation is a global term which encompasses any intervention 
designed to improve daily living for persons on dialysis.  Originally conceived as a 
program to assist patients’ return to the workforce (Oberley, Sadler, & Alt, 2000), renal 
rehabilitation has been reconceptualized due to the aging of the dialysis population as 
promoting optimal functioning and quality of life.  The goal of renal rehabilitation is to 
increase physical activity in an effort to maintain or improve physical functioning to 
preserve independence with daily activities (Curtin, Lowrie, & DeOreo, 1999).  With the 
onset of dialysis, role function often decreases due to the dependence on others for 
medical assistance and instrumental activities of daily living, such as shopping and 
housekeeping (Thomas-Hawkins, 2004).  Intentionally targeting physical function may 
improve quality of life by allowing individuals to maintain personal activities of daily 
living, such as bathing and dressing.  Unfortunately, rehabilitation of renal patients has 
received minimal attention (Thomas-Hawkins, 2004), most likely due to start up costs 
involved and limited research documenting potential cost savings.  Even though ESRD is 
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not curable, “optimizing functioning is a real possibility and an achievable goal” (Curtin 
et al., 1999, p. 139).  Nurses can play a vital role in developing, administering, and 
evaluating rehabilitation programs for persons with ESRD.  Quality of life can be an 
important endpoint for validating the success of a renal rehabilitation program.   
Thus, monitoring quality of life in persons with ESRD may assist with improving 
quality of life through progressive palliative care services, active self-management 
strategies, and renal rehabilitation.  These interventions should assist persons with ESRD 
to achieve longer periods of stability during the chronic phase, minimize downward 
phases, and perceive a higher quality of life.  Understanding factors contributing to 
quality of life may help identify which interventions could have the most influence on 
overall quality of life.   
 Improving Quality of Death.  In addition to improving quality of life, evaluating 
quality of life may also improve quality of death.  Research has shown that quality of life 
is related to end of life.  Data from the International Dialysis Outcomes and Practice 
Patterns Study (DOPPS) provided evidence that lower quality of life scores were 
associated with greater risks for death and hospitalization (Lopes et al., 2003).  In another 
study done in the U.S., a decreased quality of life in patients on hemodialysis also 
significantly correlated with death and hospitalization (Kalantar-Zadeh et al., 2001).  
Therefore, monitoring a person’s quality of life, or the factors influencing it, may assist in 
determining the end of life.   
 Knowing that the end of life is near provides persons with ESRD and their 
families the option of exploring the decision to stop dialysis and enter into hospice care.  
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Although hospice care is different from palliative care, they are often associated together.  
This confusion is due to the fact that most palliative care teams work through hospice 
agencies and are therefore considered an end-of-life support.  Hospice care has been 
shown to improve pain assessment and management, improve bereavement outcomes, 
and improve overall satisfaction with end of life care (Casarett & Quill, 2007).  However, 
these services are severely underutilized by persons with ESRD.  According to the 
National Hospice and Palliative Care Organization, 46% of hospice patients have a 
cancer diagnosis, while ESRD only comprises 3.1% (National Hospice and Palliative 
Care Organization, 2006).  Another study found that hospice was involved in less than 
10% of dialysis deaths (Holley, 2005).   
 The reasons for underutilization of hospice services in persons with ESRD are 
many.  For one, unless an intentional decision to stop dialysis is made, it is very difficult 
to identify the dying trajectory in persons with ESRD.  The typical saw tooth illness 
trajectory of life-threatening acute episodes followed by considerable recoveries blurs the 
underlying chronic downward progression.  To qualify for hospice services, the patient’s 
physician must determine that the patient has approximately six months to live.  For 
dialysis patients that often spiral towards death only to rebound, this determination is 
very difficult (Davison & Torgunrud, 2007).  In addition, when hospice services are 
requested, the patient’s Medicare benefit defaults to the hospice agency which must 
provide all final health-related needs, including dialysis.  Due to the expense, most 
hospices cannot afford to pay for dialysis services for an extended period of time (Owens, 
2006). Therefore, hospices do not typically accept patients with ESRD unless dialysis 
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treatments have been formally stopped.  The Robert Wood Johnson Foundation’s end of 
life workgroup recommended that the Medicare hospice benefit be applied to ESRD 
patients who are certified by their physicians as terminally ill, but choose to continue 
dialysis until they die (End-Stage Renal Disease Workgroup, 2002).  To date, this 
recommendation has not been heeded.  Lastly, time is an issue for mobilizing hospice 
services.  Patients and families often need to be “eased” into hospice as they readjust their 
perceptions of the gravity of the patient’s current situation (Casarett & Quill, 2007).  
Stopping dialysis usually results in death within two weeks (Moss, 2001), thus depriving 
the patient and family of time to adjust to a terminal prognosis and accepting hospice 
services.   
 These barriers to accessing hospice services need to be overcome.  Determining 
factors related to quality of life may provide essential information in monitoring the 
quality of life of persons with ESRD, and thus may assist health care providers with 
earlier recognition of the terminal phase of the chronic illness trajectory.  This earlier 
determination may allow for essential time to more effectively transition a person with 
ESRD into hospice services.   
 Both palliative care services and hospice services are underutilized in the ESRD 
population, in large part due to CMS reimbursement policies.  Without doubt, “patients 
should not be asked to choose between life-saving dialysis and palliative care” 
(Jablonski, 2007, p. 57).  As envisioned by Jablonski’s schema (see Figure 1), palliative 
services need to coincide with dialysis therapy throughout the entire chronic illness 
trajectory.  Research into the quality of life of persons with ESRD, including an 
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understanding of which factors contribute to variances in quality of life, may help inform 
clinicians and policy makers regarding this unique chronic illness trajectory and the 
interventions that are most supportive and cost-effective.   
  Much work is needed to improve the quality of life as well as the quality of dying 
for persons with ESRD.  While the quality of life of persons with ESRD has been 
examined in numerous studies (Frank et al., 2003; Loos, Briancon, Frimat, Hanesse, & 
Kessler, 2003; Weisbord et al., 2003), none have helped to inform the progression along 
the chronic illness trajectory.  Without a clearer understanding of where persons are on 
the continuum, interventions to improve quality of life may be misguided and wasted. 
Quality of life is an important measure for clinicians and researchers as they target 
palliative interventions that can maximize quality of life.  Quality of life may also be an 
important measure to assist with the identification of the terminal phase and how early 
hospice services can improve the end of life, including better management of limited 
fiscal resources.  The first step in implementing this research trajectory is understanding 
the quality of life of persons with ESRD, and what factors influence overall quality of 
life.   
Purpose 
 The purpose of this study was to describe the quality of life in persons with ESRD 
and examine factors which influence the quality of life. 
Conceptual Framework 
A revised version of Wilson and Cleary’s (1995) model for health-related quality 
of life (Ferrans et al., 2005) was used to guide this study (see Figure 2).   
13                
 
Figure 2.  Revised Wilson and Cleary Model of Health-Related Quality of Life 
 
 
 
According to this model, there are four main determinants of overall quality of life: 
biological function, symptoms, functional status, and general health perceptions.  
Characteristics of the individual and characteristics of the environment influence all of 
these determinants, as well as quality of life. 
Biological function includes the physiological processes that support life (Ferrans 
et al., 2005) and is the most fundamental determinant of health status (Wilson & Cleary, 
1995).  Biological function focuses on the performance of cells and organ systems and 
can often be measured through lab tests, physical assessment, and medical diagnosis.  
Alterations in biological function can impact all the subsequent determinants of quality of 
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life, including symptoms, functional status, and general health perceptions.  The focus of 
medical intervention is often to improve outcomes in this domain. 
Moving along the model from biological function to symptoms requires a shift 
from a cellular level to the organism as a whole (Ferrans et al., 2005).  Symptoms include 
“a patient’s perception of an abnormal physical, emotional, or cognitive state” (Wilson & 
Cleary, 1995, p. 61).  While symptoms are often related to biological function, they are 
different.  Sometimes biological changes do not produce symptoms, and sometimes 
symptoms are perceived in the absence of a biological cause.  This feature makes 
symptoms totally unique to the individual and may differ from someone who is 
experiencing the same disease process.  It is important to measure the influence of 
symptoms on overall quality of life.   
The next level of the revised Wilson and Cleary model is functional status, which 
assesses the ability to perform certain tasks (Wilson & Cleary, 1995) and is often 
influenced by biological function and symptoms.  However, it is once again important to 
measure functional status as a separate variable because it may not be completely 
correlated with biological function or symptoms.  Four domains of functioning that are 
often measured are physical, social, role, and psychological (Wilson & Cleary, 1995).  
Ferrans et al. (2005) use a more traditional approach in their revised model by focusing 
on the effects of disability on functional status and its impact on daily life.   
The next level of the model is general health perceptions, a representation of all 
health concepts together, plus others that may not be depicted by the model (Wilson & 
Cleary, 1995).  It is subjective in nature and allows for the individual to summarize all the 
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preceding concepts, placing value on the importance of each variable, to generate a 
summation of individual health.  It is a different concept than simply adding the 
preceding concepts (Ferrans et al., 2005) because it can include more than those concepts 
and is heavily subjective.  General health perception is most commonly measured with a 
single global question, indicating an overall health rating on a Likert-type scale from poor 
to excellent.   
All of these concepts ultimately impact overall quality of life  which is a person’s 
sense of well-being that stems from satisfaction or dissatisfaction with the areas of life 
that are important to him/ her (Ferrans et al., 2005).  Due to the subjective nature of many 
of the antecedents, overall quality of life is subjective and individualized.  It may also be 
conceptualized as complex and multidimensional.  Using exploratory factor analysis, 
Ferrans and Powers (1992) identified four factors which explained 91% of the total 
variance in Quality of Life Index scores:  (a) health and functioning, (b) socioeconomic, 
(c) psychological/ spiritual, and (d) family.  Thus, use of the Quality of Life Index allows 
exploration of overall quality of life, as well as four salient domains.  The health and 
functioning domain has a significant influence on the perception of the quality of one’s 
life.  In fact, the concept “quality of life” is often referred to as “health-related quality of 
life” by health care providers and researchers.  This conceptual ambiguity will be 
explored in more depth in chapter two.  
Characteristics of the individual are categorized as demographic, developmental, 
psychological, and biological factors that influence health outcomes (Ferrans et al., 
2005).  Common demographic characteristics that have been linked with health include 
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sex, age, and ethnicity.  They are usually not modifiable, but provide information 
regarding who to target for health interventions.  Developmental factors are not static, but 
are also not modifiable.  However, they should be considered when deciding which types 
of health interventions will be successful.  Psychological factors are dynamic and also 
modifiable.  They include cognitive processes which alter perceptions, such as motivation 
and beliefs.  Biological factors are the genetically linked characteristics that may manifest 
as disease, thus impacting biological function.   
Characteristics of the environment are either social or physical (Ferrans et al., 
2005).  Social characteristics include the influence of significant others, such as marriage 
partners, as well as the social milieu, such as the specific culture of a hemodialysis clinic, 
on health behavior.  Physical characteristics include the distinctive attributes of settings 
which may influence health outcomes, such as neighborhood pollution or workplace 
exercise facilities.   
The model depicts a unidirectional flow of factors toward overall quality of life.  
However, these arrows only represent the typical causal pathway (Ferrans et al., 2005).  It 
is conceivable and probable that any arrow could point in the opposite direction, 
representing the complexity of the interactions among the various factors impacting 
quality of life.     
Specific Aims 
The specific aims were: 
1. Describe the quality of life in persons with ESRD.   
Q1:  What is the quality of life in persons with ESRD? 
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2. Examine factors that may affect quality of life in persons with ESRD. 
Q2:  Do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, and 
general health perception explain overall quality of life in persons with ESRD? 
Q3:  Do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, general 
health perception, characteristics of the individual (age, gender, and race) and 
characteristics of the environment (marital status, socioeconomic status, and time 
on hemodialysis) explain overall quality of life in persons with ESRD? 
Q4:  Do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, general 
health perception, characteristics of the individual (age, gender, and race) and 
characteristics of the environment (marital status, socioeconomic status, and time 
on hemodialysis) explain dimensions of quality of life (health and functioning, 
socioeconomic, psychological/ spiritual, and family) in persons with ESRD? 
Q5:  When controlling for characteristics of the individual (age, gender, and race) 
and characteristics of the environment (marital status, socioeconomic status, and 
time on hemodialysis), do biological function (serum albumin and serum 
hemoglobin), symptoms (dialysis symptoms, anxiety, depression, and fatigue), 
functional status, and general health perception explain overall quality of life in 
persons with ESRD? 
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Definitions 
 The following terms are defined for the purpose of this study: 
1. Persons with end stage renal disease (ESRD):  Persons who have been diagnosed by a 
nephrologist as having stage 5 chronic kidney disease requiring renal replacement 
therapy, such as dialysis.  For this study, only persons on hemodialysis were included.   
2. Hemodialysis:  A process by which blood is artificially cleansed in the absence of 
normal kidney function.  During this process, blood is diverted from the body through 
an arterio-venous access, pumped through an extra-corporeal circuit where waste 
products and excess fluid diffuse through a semipermeable membrane for disposal, 
and the cleansed blood is returned to the body.  All persons attending the dialysis 
clinic and connected to the hemodialysis machine via an arterio-venous access were 
considered to be undergoing hemodialysis.   
3. Quality of life:  A person’s sense of well-being that stems from satisfaction or 
dissatisfaction with the areas of life that are important to him/ her (Ferrans et al., 
2005).  For this study, quality of life was operationalized as the score on the Quality 
of Life Index- Dialysis Version- III (Ferrans & Powers, 1985). 
4. Biological function:  Molecular, cellular, and organ processes that support life 
(Wilson & Cleary, 1995).  For this study, biological function was measured by the 
most recently documented serum albumin (grams/ Liter) and serum hemoglobin level 
(grams/ deciliter) in the participant’s medical record.   
5. Symptoms:  A person’s perception of an abnormal physical, emotional, or cognitive 
state (Ferrans et al., 2005; Wilson & Cleary, 1995).  For this study, symptoms were 
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measured in three separate ways:  (a) the score on the Dialysis Symptom Index 
(Weisbord et al., 2004),  (b) the score on the Hospital Anxiety and Depression Scale 
(Zigmund & Snaith, 1983), and (c) the score in millimeters on a fatigue visual analog 
scale (Wolfe, 2004).   
6. Functional status:  The ability to perform tasks of daily living, including personal, 
instrumental, and social tasks, and the actual performance of these tasks, as measured 
by the score on the Inventory of Functional Status- Dialysis (Thomas-Hawkins, 
2004). 
7. General Health Perceptions:  An overall perception of wellness that is individualized 
and subjective.  For this study, general health perceptions was operationalized as the 
score on one global question, “How would you rate your health on a scale from 1 to 
10, with 1 = poor and 10 = excellent?” (Ferrans et al., 2005).   
8. Characteristics of the individual:  Demographic, developmental, psychological, and 
biological factors that influence health outcomes (Ferrans et al., 2005).  For this 
study, characteristics of the individual was the determination of three representative 
variables: (a) age of the participant in years according to the medical record, (b) 
gender (male or female) according to the medical record, and (c) self-reported race 
(white, African American, Hispanic, or other). 
9. Characteristics of the environment:  Social or physical factors present in the person’s 
setting or situation which influence health.  For this study, characteristics of the 
environment was the determination of three representative variables:  (a) self-reported 
marital status (single, married, separated, divorced, or widowed), (b) self-reported 
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poverty status (poverty/ no poverty) according to a poverty income grid, and (c) time 
on hemodialysis in months according to the medical record, including episodes 
separated by periods of peritoneal dialysis or transplantation. 
Assumptions 
Assumptions underlie the methods used in this study.  The first assumption 
addresses the belief that quality of life exists as a multi-dimensional construct.  In 
addition, abstract and unobservable concepts, such as symptom burden and health 
perception, can be quantified and tested through instrumentation and statistical analysis.  
Furthermore, persons with ESRD will accurately and honestly answer questions that 
measure symptom burden, physical function, general health perception, quality of life, 
individual characteristics, and environmental characteristics.  The final assumption is that 
data from the medical record reflect reality. 
Summary 
 The purpose of this research was to describe the quality of life of persons with 
ESRD, including influencing factors.  A revised version of Wilson and Cleary’s model 
for health-related quality of life (Ferrans et al., 2005) was used to guide the study.  The 
results of this study will assist investigators to begin a larger research trajectory of 
monitoring quality of life and determining interventions to maximize it by targeting 
influencing factors.  In addition, quantification of quality of life may assist researchers in 
determining the terminal phase of the chronic illness trajectory allowing for early 
mobilization of hospice services at the end of life for persons with ESRD. 
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CHAPTER II 
 
LITERATURE REVIEW 
 
 
Introduction 
 
The term “quality of life” entered the American vocabulary after World War II to 
emphasize that “the good life” was more than just wealth (Campbell, Converse, & 
Rodgers, 1976).  Since then, it has been an important concept for health care providers as 
well as social policy makers.  However, the term is multidimensional and no clear 
definition has been agreed upon by those who use the phrase (Ferrans & Powers, 1992; 
Kimmel, 2000), including scientists who quantify it.  The ambiguity surrounding the term 
is “complex and contentious” (Tyrrell, Paturel, Cadec, Capezzali, & Poussin, 2005, p. 
375).  This conceptual confusion has created a significant shortcoming in the literature 
when quality of life studies are compared and synthesized.   
Current Theoretical Views on Quality of Life 
Quality of life is most often described in one of two ways: satisfaction or 
happiness (Ferrans & Powers, 1992).  While happiness tends to denote a more fleeting, 
unstable emotion, satisfaction implies a more permanent state that stems from core 
values.   While social scientists were grappling with the philosophical distinctions 
between happiness and satisfaction, health providers became interested in the concept as 
it related to their patients.  Because health has such a large impact on perceived quality of 
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life, the phrase began to take on even more meanings, including well-being, psychosocial 
adjustment, physical functioning, symptoms and health status (Ferrans et al., 2005).   
Most scientists agree that quality of life is composed of various dimensions which 
impact it, but no consensus has been reached on the essential dimensions.  In a synthesis 
of various studies, quality of life dimensions have included life satisfaction, 
socioeconomic status, physical health, affect, perceived stress, friendship, family, 
marriage, life goals, housing and neighborhood, city and nation, self-esteem, depression, 
psychological defense mechanisms, and coping (Ferrans & Powers, 1985).  In an attempt 
to clarify the conceptual confusion, the term “health-related quality of life” was coined to 
denote the effects of health, illness, and treatment on overall quality of life (Ferrans et al., 
2005; Kimmel, 2000), or the impact of disease on important areas of one’s life (Phillips, 
Davies, & White, 2001).  Most health-related quality of life studies include a physical 
functioning measure (Laws, Tapsell, & Kelly, 2000; Painter, Carlson, Carey, Paul, & 
Myll, 2000; Patel, Shah, Peterson, & Kimmel, 2002; Phillips et al., 2001), and sometimes 
this is the only measure of health-related quality of life (Kimmel, 2000).   
From this conceptual stance, health-related quality of life does not include factors 
such as cultural, political, or societal attributes (Ferrans et al., 2005).  For nurses who 
most often subscribe to a holistic worldview, however, virtually all areas of life are 
affected by health and conversely, health affects all areas of one’s life.  It is virtually 
impossible to separate out the influence of cultural, political, or societal attributes on 
health, and thus quality of life.  For example, political oppression can lead to decreased 
access to care, and cultural dietary practices can undermine therapeutic diets.  Viewed 
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through a holistic lens, human beings are bio-psycho-social beings.  Thus, their quality of 
life is more than their health.   
Since the term “health-related quality of life” started being used, it has been 
almost impossible to separate it from the more global “quality of life.”  The two terms are 
often used interchangeably within the same research report (Bakewell, Higgins, & 
Edmunds, 2001; Drayer et al., 2006; Morsch, Goncalves, & Barros, 2006) without any 
conceptual clarification.  In general, however, health researchers tend to subscribe to one 
of two views: (a) a holistic, global framework; or (b) a disease-based, deficit framework. 
Proponents of both views may interchange the terms “quality of life” and “health-related 
quality of life,” so it may not always be clear which perspective guides the study.  An 
example of a global framework is the Register theory of Generative Quality of Life for 
the Elderly (Register & Herman, 2006).  This middle-range theory incorporates six ways 
that people are connected to salient life dimensions that together impact quality of life: 
metaphysically connected, spiritually connected, biologically connected, connected to 
others, environmentally connected, and connected to society.  The person is viewed in 
totality and health may impact connections in any of the forces.  An example of a 
disease-based, deficit framework is Wilson and Cleary’s health-related quality of life 
conceptual model (Wilson & Cleary, 1995).  In developing their model, Wilson and 
Cleary wanted to focus on the physical components of quality of life.  They determined a 
need for a physiologically-based framework because previous models had “foundations 
in sociology, psychology, and economics and use concepts and methodologies often 
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foreign to physicians and clinical researchers” (p. 59). Therefore, their model emphasizes 
the impact of health and disease on quality of life.      
 In addition to Register and Herman (2006) and Wilson and Cleary (1995), other 
conceptual models of quality of life exist, including models from other disciplines, such 
as the economically-based model depicting a causal chain of well-being involving 
perceived income adequacy (Cummins, 2005).  Health researchers have not endorsed any 
one model or even narrowed the field.  Indeed, many researchers do not refer to any 
specific theoretical framework of any kind when reporting their research results (Loos et 
al., 2003; Lopes et al., 2003; Merkus et al., 1999; Sesso, Rodrigues-Neto, & Ferraz, 
2003).   
Without conceptual clarity, one must examine the domains often associated with 
quality of life and health-related quality of life research to better understand the 
conceptual foundation.  Once again, no consensus has been reached regarding the salient 
domains that must be included in any measure of quality of life.  Life satisfaction is often 
included in measures of quality of life (Ferrans & Powers, 1985), and one of the earliest 
theorists in the quality of life field conceptualized quality of life as a fit between 
aspirations and actual life experiences (Campbell, 1981).   The most common domains 
found in the health literature, including studies involving persons with ESRD (Cleary & 
Drennan, 2005; Tyrrell et al., 2005), usually include at least physical, psychological, and 
social components.  Other domains often include work life (Phillips et al., 2001), 
spirituality (Patel et al., 2002; Weisbord et al., 2003), general health perceptions (Phillips 
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et al., 2001), self-esteem (George & Bearon, 1980), socioeconomic status (George & 
Bearon, 1980), and activity level (Phillips et al., 2001).   
Although identifying domains associated with a concept is helpful in 
understanding causal and influential relationships, it does not clearly identify the meaning 
of the concept.  Unfortunately, defining the term “quality of life” has also been elusive.  
Wilson and Cleary (1995) did not define the term.  They stated, “Health status and 
health-related quality of life can refer to different concepts, but in this article we use the 
terms interchangeably” (p. 60).  Ferrans and Powers (1992) specifically define quality of 
life as “a person’s sense of well-being that stems from satisfaction or dissatisfaction with 
the areas of life that are important to him/ her” (p. 29).  This definition includes the 
satisfaction factor, which denotes a more permanent kind of well-being, as well as the 
belief that different people have different values which impact their perception of quality 
of life.   
Quality of Life in Persons with ESRD 
Quality of life is a concept that has been studied in persons with ESRD.  Findings 
indicate that persons with ESRD have a lower quality of life than the general public 
(Cleary & Drennan, 2005; DeOreo, 1997; Ferrans & Powers, 1993; Frank et al., 2003; 
Merkus et al., 1999).  This lower quality of life may be related to the complications 
associated with ESRD that significantly impact quality of life (Phillips et al., 2001).  
More concerning is that persons with ESRD have a lower quality of life than persons 
with other chronic illnesses (Loos et al., 2003), and that quality of life is correlated with 
hospitalization and death in persons with ESRD (DeOreo, 1997).  However, these studies 
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and others using quality of life as a variable are difficult to interpret and synthesize due to 
a lack of conceptual clarity.  The authors often did not provide a definition of quality of 
life (Patel et al., 2002; Weisbord et al., 2003), explicate specific domains associated with 
quality of life (Laws et al., 2000; Sesso et al., 2003), nor specify a conceptual model 
which guided the study design and analysis (Kalantar-Zadeh et al., 2001; Merkus et al., 
1999).  The term “health-related quality of life” was more prevalent than the more global 
“quality of life,” although many studies interchanged the two terms (Bakewell et al., 
2001; Drayer et al., 2006; Morsch et al., 2006).  Unfortunately, without conceptual detail, 
it is unclear what was being studied. 
Only a few studies on quality of life in persons with ESRD were found that made 
an attempt at a definition of quality of life or health-related quality of life.  Many reports 
stated in various ways that quality of life (or health-related quality of life) is a patient’s 
subjective sense of well-being (Baiardi et al., 2002; Ferrans & Powers, 1993; Greene, 
2005; Kalantar-Zadeh et al., 2001).  Other authors used the medical model approach and 
defined the term according to self-reported health status and functioning (Curtin, 
Bultman, Thomas-Hawkins, Walters, & Schatell, 2002; DeOreo, 1997; Morsch et al., 
2006; Painter et al., 2000).  One study used both (Frank et al., 2003).  The majority of 
studies, however, did not attempt to define the concept or clarify the salient domains 
associated with it.   
Without clearly delineated domains and definitions, conceptual clarity can still be 
achieved through the application of a conceptual framework, model, or theory.  However, 
this, too, is missing from the ESRD literature.  From 25 studies examined for domains 
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and definitions, only three provided a theoretical foundation in which to ground their 
research.  One used Wilson and Cleary’s health-related quality of life framework (Frank 
et al., 2003), and another used a palliative care model which was more appropriate for the 
nature of the research (Jablonski, 2007).  The third study was done by Ferrans and 
Powers (1993) and used a conceptual approach to quality of life derived from their 
Quality of Life Index.   Interestingly, these studies were conducted by social workers 
(Frank et al., 2003) and nurses (Ferrans & Powers, 1993; Jablonski, 2007).  One caveat to 
the lack of quality of life definitions, domains and frameworks must be mentioned.  Many 
journals do not have space for elucidating conceptual frameworks which provide the 
foundation for scientific inquiry.  However, one must wonder whether conceptual haze 
and not journal space is more the issue.  By not including at least the name and reference 
of the guiding framework, results can not be readily synthesized with similar studies to 
support and revise existing patterns of thought around a phenomenon.  In addition, the 
results may be vulnerable to misinterpretation if consumers of research reports must align 
the findings within their own conceptual understanding.  These consequences risk 
impeding scientific knowledge development.   
Without a definition or conceptual framework, another way to understand a 
concept is to examine the instruments used to measure it.  Often the subscales of an 
instrument are the conceptual domains, thereby providing theoretical insight.  Most 
subscales are derived from a statistical factor analysis.  By far, the most popular tool in 
the ESRD literature on quality of life is the Medical Outcomes Study 36-item Short Form 
Health Survey (SF-36) (Ware & Sherbourne, 1992) and the Kidney Disease Quality of 
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Life Short Form (KDQOL-SF) which uses the SF-36 as its core (Korevaar et al., 2002).  
The SF-36 is a general health questionnaire and is referred to in studies as a measure of 
quality of life, health-related quality of life, physical and mental functioning, patient-
assessed functional health status, general health, and health outcomes.  The SF-36 has 36 
items and eight scales:  physical functioning, role-physical, bodily pain, general health, 
vitality, social functioning, role-emotional, and mental health.  In addition to scale scores, 
two summary scores are provided:  physical component summary and mental component 
summary.  The instrument items are all geared toward health-related concerns.  For 
example, an item on the social functioning scale asks to what extent physical health or 
emotional problems (emphasis included in the scale) have interfered with social 
activities.  The KDQOL-SF includes all the SF-36 items, plus 43 additional questions to 
assess concerns specific to persons on hemodialysis.  It retains the physical component 
summary scale and the mental component summary scale of the SF-36, plus a kidney 
disease component summary.   
In a review of ESRD quality of life studies, Kimmel (2000) reported that a wide 
range of instruments have been used to measure quality of life and health-related quality 
of life in this population, including the Karnofsky Performance Scale (a physical 
functioning scale), the Beck Depression Inventory, the Multidimensional Scale of 
Perceived Social Support, and the Illness Effects Questionnaire.  Clearly, from this 
listing, conceptual incongruence exists.  It appears that one aspect or domain of quality of 
life may be being used synonymously with the larger construct of quality of life.  Kimmel 
reviewed studies primarily from medical journals, which often do not have the holistic 
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focus that nursing journals do.  Thus, the concept of quality of life was viewed more 
narrowly as health status, and various measures of health status were used as measures of 
quality of life.   
The other quality of life instrument that has been used with some frequency in the 
ESRD population is Ferrans and Powers’ (1985) Quality of Life Index- Dialysis Version.  
This instrument has four subscales:  health and functioning, social and economic, 
psychological and spiritual, and family.  This structure was derived from factor analysis, 
and the authors used this grouping to describe a conceptual framework (Ferrans, 1996).  
The underlying domains are more holistic than the SF-36.  Recent use of this tool was by 
non-physicians—dieticians (Laws et al., 2000), physical therapists (Greene, 2005), and 
nurses (Bihl, Ferrans, & Powers, 1988; Ferrans & Powers, 1993; Jablonski, 2007).   
The quality of life studies involving persons with ESRD (and most probably other 
patient populations) are conceptually weak.  Without a theoretical basis, consistently 
delineated domains, common definition, nor an agreed upon term for the concept, it is 
difficult to interpret and synthesize the findings.  One could argue that instead of 
measuring quality of life, the actual variable being measured is quality of health.  While 
this may be the intent with the use of the phrase “health-related quality of life,” the 
resulting confusion has hampered efforts at measuring the more holistic quality of life.   
Research with persons with ESRD is needed which explores quality of life 
conceptualized as a holistic expression summarizing the totality of satisfaction with one’s 
life.  While health is a dominant component of this concept, it cannot be separated from 
other influences which impact one’s subjective perception regarding well-being.  The 
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reductionistic efforts of previous studies to explain quality of life by compartmentalizing 
the health-related factors has resulted in uninterpretable findings.  For example, the 
studies which have found that the quality of life for persons with ESRD is lower than the 
general public (Cleary & Drennan, 2005; DeOreo, 1997; Frank et al., 2003; Merkus et al., 
1999) leaves one to question whether the quality of life is lower or whether health status 
is lower.  The SF-36 queries, “To what extent do physical health or emotional problems 
interfere with social activities?”  Certainly persons undergoing thrice weekly 
hemodialysis will experience interference with social activities due to their illness.  
However, this does not measure the quality of those relationships nor the satisfaction 
derived from them.     
One holistic model that may provide theoretical strength to quality of life research 
is the revised Wilson and Cleary model of health-related quality of life (Ferrans et al., 
2005).  Although the conceptual model is labeled a health-related quality of life model, it 
is more of a quality of life model than a health-related quality of life model.  The basis 
for this contention lies in examination of the characteristics of the individual and the 
characteristics of the environment (see Figure 2). Ferrans et al. elucidated an ecological 
model of influence for these two variables which expanded their scope well beyond 
health-related control.  By including the influence of intrapersonal, interpersonal, 
institutional, community, and public policy factors, overall quality of life is affected by 
more than health.  The fact that the arrows emanating from characteristics of the 
individual and the characteristics of the environment point not only to the antecedents of 
quality of life, but directly to overall quality of life as well, indicate that their influence 
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on quality of life need not be exclusively mediated by health-related factors, such as 
biological function, symptoms, and functional status.  Both Ferrans et al. and Wilson and 
Cleary indicate that the direction of the arrows can be reversed to show reciprocal 
relationships, and that the absence of arrows between levels does not imply that 
relationships do not exist.  This complexity allows for characteristics of the environment 
to influence characteristics of the individual, which can impact overall quality of life.  
This pathway is important because it signifies that a completely non-health-related factor, 
such as lack of local entertainment, can influence the psychological component of 
characteristics of the individual, which can in turn effect the perception of overall quality 
of life.   
Biological Function 
According to the revised Wilson and Cleary model of health-related quality of life 
(Ferrans et al., 2005), four factors—biological function, symptoms, functional status, and 
general health perceptions—influence overall quality of life.  Biological function is the 
most basic determinant of quality of life because it involves cellular and organ level 
impairment.  Two biological factors that may impact quality of life in persons with ESRD 
are malnutrition and anemia.   
Many factors contribute to malnutrition in renal failure, including anorexia, 
metabolic acidosis, endocrine disorders, co-morbidities, systemic inflammation, reduced 
nutrient intake, inadequate dialysis, intra-dialytic protein losses, depression, and the cost 
of high quality food (Goldstein-Fuchs, 2006).  These factors deplete the amount of 
protein available to meet essential amino acid requirements by the body for cellular 
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generation.  Of the proteins lost daily, 50-80% is as albumin (Goldstein-Fuchs, 2006).  
Severe malnutrition has been associated with decreased quality of life (Laws et al., 2000), 
and albumin levels have been positively correlated with the physical component scale of 
the SF-36 (Lopes et al., 2007; Morsch et al., 2006), as well as the mental component 
scale (Frank et al., 2003; Kalantar-Zadeh et al., 2001).  One study did not find a 
significant correlation between albumin and quality of life (Patel et al., 2002).  However, 
this study used a single global question to assess quality of life, which may be a narrow 
conceptualization of quality of life according to the revised Wilson and Cleary conceptual 
model (Ferrans et al., 2005). In addition, low albumin has been identified as a significant 
predictor of mortality (DeOreo, 1997; Lowrie & Lew, 1990).  Therefore, studies 
examining albumin as an important component of biological function are needed.   
Anemia has also been shown to impact quality of life in persons with ESRD.  
Low hemoglobin levels result in poor oxygen-carrying capacity of red blood cells. The 
associated symptoms include fatigue, poor concentration, decreased appetite, palpitations, 
angina, and reduced libido (Candela & Parker, 2006).  Although studies have shown that 
hemoglobin is positively correlated with quality of life (Baiardi et al., 2002; Lopes et al., 
2007; Morsch et al., 2006), some studies have not shown such a correlation (Frank et al., 
2003; Kalantar-Zadeh et al., 2001; Patel et al., 2002).  The reason for this inconsistency 
may be the measurement of quality of life.  One study used a single global measure (Patel 
et al., 2002), and the other two used the SF-36, a narrow, health-related instrument to 
quantify quality of life.  Another reason for inconsistent correlations may be that most 
persons with ESRD receive erythropoietin therapy to increase red blood cell production.  
33                
 
This therapy has significantly decreased anemia in the ESRD population (Candela & 
Parker, 2006).  However, other factors can also contribute to anemia, including 
hyperparathyroidism, iron and folate deficiency, decreased red blood cell lifespan due to 
uremia, and increased potential for bleeding due to platelet dysfunction (Candela & 
Parker, 2006).  In addition, anemia management can be very challenging for the health 
care provider due to individual patient differences creating inconsistent responses to 
therapy.  Thus, maintaining hemoglobin levels according to published clinical practice 
guidelines is difficult and both high and low hemoglobin levels are common (Candela & 
Parker, 2006).  Therefore, the role of anemia as a biological factor impacting quality of 
life in persons with ESRD is still unclear and warrants further research.    
Symptoms 
According to the revised Wilson and Cleary model of quality of life (Ferrans et 
al., 2005), the physical and emotional burden from symptoms is crucial in understanding 
quality of life.   Often, health care providers do not understand the value that 
hemodialysis patients place on their symptoms (Weisbord et al., 2004).  In a systematic 
review of 59 studies which addressed symptoms experienced by persons on hemodialysis 
(Murtagh, Addington-Hall, & Higginson, 2007), the top reported symptoms and their 
weighted mean prevalence were: fatigue (71%), pruritis (55%), constipation (53%), 
anorexia (49%), pain (47%), sleep disturbance (44%), anxiety (38%), dyspnea (35%), 
nausea (33%), restless legs (30%), and depression (27%).  The wide range of symptoms 
has also been reported in another study in which 22 out of 47 symptoms were 
experienced “at least some of the time” (Curtin, Bultman, et al., 2002).  The mean 
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number of symptoms experienced per person has been reported as 5.67 (Jablonski, 2007), 
7.7 (Frank et al., 2003), and 9.8 (Weisbord et al., 2004).  Although these studies are not 
comparable due to the wide range of assessment tools used, clearly persons with ESRD 
experience many symptoms related to their disease.  Symptom distress in the ESRD 
population has been positively correlated with co-morbidities (Weisbord et al., 2003), and 
negatively correlated with functional status (Thomas-Hawkins, 2000).  In addition, 
symptom burden has been correlated with a decreased quality of life (Curtin, Bultman, et 
al., 2002; Weisbord et al., 2003).  One study found that symptom scores, level of relief, 
and satisfaction with relief accounted for 28% of the variance in quality of life (Jablonski, 
2007); while another found that severity of symptoms accounted for 44% variance in the 
physical component scale of quality of life (Frank et al., 2003).  Besides the fact that 
symptoms are a main variable in the revised Wilson and Cleary quality of life model, the 
significant influence of dialysis symptoms on quality of life necessitates further 
validation to build evidence for palliative services in this vulnerable population.   
A few symptoms experienced by persons on hemodialysis have been explored in 
the literature in more depth. Fatigue is the most commonly reported symptom by persons 
undergoing hemodialysis (Murtagh et al., 2007).  Prevalence has been reported at 74% 
(Weisbord et al., 2003), 77% (Jablonski, 2007), 82% (Merkus et al., 1999), 84% (Frank et 
al., 2003), and 90% (Curtin, Bultman, et al., 2002).  Fatigue is often underreported in the 
hemodialysis population because patients expect fatigue to go along with chronic disease 
(Srivastava, 1986). However, many times fatigue can be lessened if the underlying 
cause(s), such as anemia, depression, dialysis inadequacy, or the effects of 
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antihypertensive medications, can be mitigated (Srivastava, 1986).  Because fatigue is 
such an obvious symptom burden in persons with ESRD and contributes quite 
significantly to overall quality of life, it warrants special consideration as a separate 
variable in the symptom domain of the revised Wilson and Cleary model (Ferrans et al., 
2005).   
Another symptom worth exploring in more depth is anxiety.  Although 38% of 
persons on hemodialysis report anxiety (Murtagh et al., 2007), it has not been addressed 
in any studies involving quality of life in persons with ESRD.  Measuring anxiety as a 
separate variable will contribute new knowledge regarding the influence of anxiety on 
overall quality of life for persons with ESRD. 
Although anxiety and depression are often correlated, depression has been 
addressed in much greater depth in the quality of life literature for persons with ESRD.  
Depression is present in approximately 28% of persons with ESRD (Drayer et al., 2006; 
Murtagh et al., 2007; Weisbord et al., 2005), and as much as 61% in older dialysis 
patients (Tyrrell et al., 2005). Unfortunately, it is often not diagnosed in this population 
because the symptoms associated with depression mimic many of the symptoms 
prevalent in the hemodialysis population, such as fatigue, sleeping problems, and 
decreased appetite. However, the presence of depression has been associated with a 
decreased quality of life (Drayer et al., 2006; Patel et al., 2002; Walters, Hays, Spritzer, 
Fridman, & Carter, 2002) and a fourfold risk of death (Drayer et al., 2006).  
Understanding the individual contribution of depression and anxiety to quality of life is 
needed. Measuring each as a separate variable, in addition to their contribution to overall 
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symptom burden, will provide greater insight into symptoms and the influence of 
symptoms on quality of life.   
Functional Status 
Functional status is defined in various ways, but usually refers to the ability to 
perform certain tasks (Wilson & Cleary, 1995).  These tasks may by physical, social, 
psychological, or role-related (Ferrans et al., 2005).  Thomas-Hawkins (2004) defines 
functional status as the “ability to perform and the actual performance of daily activities” 
(p. 687).  This definition includes both activities of daily living (ADL), such as dressing, 
eating, and hygiene; and instrumental activities of daily living (IADL), such as shopping, 
housekeeping, and transportation.  In addition, the definition includes both what persons 
are capable of doing, and what they actually do, as these are different dimensions of 
functioning (Thomas-Hawkins, 2004).   
Physical functioning includes four dimensions:  functional capacity (maximum 
capacity to perform a specific task), functional performance (day-to-day activities), 
functional capacity utilization (percentage of functional capacity that is used day to day), 
and functional reserve (the difference between capacity utilization and functional 
capacity) (Leidy, 1994).  Functional capacity is an intense way to measure function by 
requiring physical movement to the point of exhaustion.  It works best for measuring one 
specific task, versus determining a global understanding of physical functioning.  It is 
usually not appropriate for frail populations.  No instruments have been developed for 
measuring functional capacity utilization or functional reserve (Leidy, 1994).  Functional 
performance, which measures day-to-day activities, is an appropriate measure for persons 
37                
 
with ESRD to determine functional status.  This conceptualization of functional status is 
an important component of what persons with ESRD include in their descriptions of 
quality of life (Thomas-Hawkins, 2004).   
Physical functioning is often limited in persons with ESRD, usually due to 
symptoms or treatment regimen, and not renal failure itself (Painter, Stewart, & Carey, 
1999).  The exercise capacity of persons on dialysis is half that of the normal population 
(Curtin et al., 1999).  In addition, renal patients face progressive debilitation and 
deconditioning, and most can not do more than attend to activities of daily living (Curtin 
et al., 1999).  Further, older persons on dialysis have even lower physical functioning 
than their younger counterparts (Thomas-Hawkins, 2000).   
Functional status is predictive of death in all populations, including persons with 
ESRD (Curtin et al., 1999).  In a recent pilot study which looked at predictors of end of 
life during multiple hospitalizations in persons with ESRD, two predictors showed a 
significant change from the admission prior to death and the death admission (Kring & 
Crane, 2007). One variable was a measure of function and the other a measure of 
pressure ulcer risk, which included many functional indicators.  These functional 
variables were more predictive of death than the physiological variables, including mean 
arterial pressure, pulse, temperature, weight, albumin, hemoglobin, and HgbA1c. 
Functional status is modifiable, and persons who manage to maintain independent 
function have reported a higher quality of life (Molzahn, 2006).  One study found that 
both an independent home exercise program and an in-center cycling program increased 
physical functioning and the physical component scale of the SF-36 (Painter et al., 2000).  
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Although physical functioning is an important domain within quality of life, most quality 
of life studies involving persons with ESRD did not measure function as a separate 
variable from quality of life.  In fact, the use of the SF-36, often referred to as a health-
related quality of life scale, is also frequently referred to as a measure of functional 
status—both physical and mental.  Therefore, for many researchers, health-related quality 
of life and functional status are synonymous.  Those studies that did measure physical 
function as a separate variable to correlate with quality of life used the Karnofsky 
Performance Scale (KPS) (Laws et al., 2000; Patel et al., 2002).  This scale is commonly 
used within the dialysis population and some dialysis centers routinely complete the KPS 
on all patients.  The KPS measures functional impairment related to disease progression 
and the amount of assistance or medical care needed to manage the disease process (Mor, 
Laliberte, Morris, & Wiemann, 1984).  It provides an 11-point scale of function, with 
100% indicative of full functioning and no evidence of disease; and 0% indicative of 
death.  The KPS has since been updated to include more descriptors for classifying 
function according to ambulation, activity, evidence of disease, self-care, intake, and 
consciousness, and deleting references to hospitalization given many patients’ desire to 
be cared for at home.  This updated tool is known as the Palliative Performance Scale 
(PPS) (Anderson, Downing, Hill, Casorso, & Lerch, 1996).  The PPS has not been used 
in the renal population.  Therefore, research is needed which uses the more up-to-date 
PPS with the ESRD population as a measure of function.  In addition, research is needed 
which examines the impact of physical functioning as a separate variable on quality of 
life in persons with ESRD, especially with a tool designed to measure ADL and IADL.   
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General Health Perceptions 
General health perception is a representation of all health concepts together, plus 
any not specifically captured in another variable or instrument (Wilson & Cleary, 1995).  
It is individualized, completely subjective, and based on a concept first articulated by 
Campbell, Converse, and Rodgers (1976) which determined overall satisfaction with life 
using a single measure.  It is still most commonly measured with one global question 
using a Likert-type scale to measure satisfaction with health (Ferrans et al., 2005).  
Including general health perception in a conceptual model of quality of life allows for 
additional subjective input which summarizes not only the biological function, 
symptoms, and functional status, but also incorporates characteristics of the individual, 
characteristics of the environment, and other non-identified antecedents of quality of life.  
It may help explain a portion of quality of life that other instruments are unable to capture 
because the construct “quality of life” is so complex.  
Many health-related quality of life instruments include a question regarding 
general health perception, including the SF-36.  However, the vast majority of studies 
examining quality of life in persons with ESRD do not single out this variable for 
statistical analysis.  One study reported the general health perception of persons with 
ESRD using Campbell’s Overall Life Satisfaction Item and correlated it with various 
nutritional statuses (Laws et al., 2000).  The investigators reported that severely 
malnourished renal patients had significantly lower general health perceptions (and 
scored lower on other quality of life domains) than patients who were well nourished or 
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moderately malnourished.  Unfortunately, regression analysis was not done to determine 
the contribution of this domain on overall quality of life.   
In accordance with the revised Wilson and Cleary model of health-related quality 
of life (Ferrans et al., 2005), general health perception should be included in studies of 
quality of life.  It is a frequently overlooked variable and including it as a separate 
variable in quality of life studies with persons with ESRD may help explain a subjective 
and individualized component of quality of life not captured by other instruments.   
Characteristics of the Individual 
Characteristics of the individual are demographic, developmental, psychological, 
and biological factors that influence health outcomes (Ferrans et al., 2005).  They impact 
all antecedents of quality of life, thereby moderating their influence.  For the proposed 
study, age, gender, and race/ ethnicity have been selected as important characteristics of 
the individual that may impact quality of life in persons with ESRD.  
Age is often used to describe the sample in studies examining quality of life in 
persons with ESRD, and sometimes it is explored as an independent variable.  In a study 
of dialysis persons over the age of 70, 15% were found to have a very poor quality of life, 
although the range of scores was large (Tyrrell et al., 2005).  Most studies have found 
that older persons with ESRD have a decreased quality of life than younger persons with 
ESRD (Baiardi et al., 2002; Ferrans & Powers, 1993; Frank et al., 2003; Lopes et al., 
2007; Walters et al., 2002).  However, one study found that younger dialysis patients 
(aged 26-45) had a significantly lower quality of life than a 56-65 age group, and a 66 
and older age group (Greene, 2005), as measured by the holistic Quality of Life Index- 
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Dialysis version. The sample was limited to African Americans on hemodialysis living in 
a metropolitan area, and thus the findings may be related to culture rather than age.  A 
study of Brazilian hemodialysis patients also found that age was not associated with 
quality of life (Morsch et al., 2006), which is an interesting finding given that quality of 
life was measured with the SF-36.  The investigators in both studies hypothesized that 
older persons were more accepting of decreased limitations than younger persons.  Given 
these results, and the association of age with physical function (Thomas-Hawkins, 2000), 
further investigation is needed regarding the impact of age on quality of life in persons 
with ESRD. 
A few studies have examined the influence of gender on quality of life in persons 
with ESRD, also with mixed results.  Three studies have found no differences in quality 
of life between men and women (Baiardi et al., 2002; Ferrans & Powers, 1993; Kalantar-
Zadeh et al., 2001). However, two of these studies used the SF-36 (Baiardi et al., 2002; 
Kalantar-Zadeh et al., 2001), which is not a holistic measure of quality of life.  
Conversely, one study which also used the SF-36 found that men reported a higher 
quality of life than women (Frank et al., 2003).   Two studies found that women and men 
were different on various domains of quality of life.  Lopes et al. (2007) found that 
women had significantly lower quality of life related to symptoms and problems, but 
higher quality of life related to social interaction and sexual function, as measured by the 
Kidney Disease Quality of Life- Short Form (KDQOL-SF), which uses the SF-36 as its 
core. Walters et al. (2002), using the same instrument, found that women had 
significantly lower quality of life related to physical functioning, pain, emotional well-
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being, and energy/ fatigue, but higher quality of life related to sexual function.  Again, 
the studies to date have not provided adequate information regarding the influence of 
gender on perception of quality of life.  All of the ESRD studies reporting gender as an 
independent variable except one used the SF-36, or a version of it, to measure quality of 
life.  Using a more holistic measure of quality of life may yield different results.  
Examining race/ ethnicity as an individual characteristic is also important when 
studying quality of life in persons on dialysis.  Again, the results in the ESRD population 
have been limited and mixed.  One Israeli study divided participants into two groups—
Asian/ African and European/ American (Frank et al., 2003), and found that Asian/ 
African patients reported a significantly greater decrease in quality of life over time.  
Two studies reported that African Americans had a higher quality of life than Whites 
(Lopes et al., 2003; Weisbord et al., 2003).  However, three other studies found no 
differences in racial/ ethnic influences on quality of life (Bakewell et al., 2001; Ferrans & 
Powers, 1993; Morsch et al., 2006).  Race is an important consideration in the ESRD 
population because the relative risk of ESRD for African Americans is 3.52 compared to 
Whites (Li, McAlpine, Liu, & Collins, 2004).  Including race/ ethnicity in future studies 
will provide additional information regarding racial and ethnic perceptions of quality of 
life. 
Age, gender, and race/ ethnicity are examples of characteristics of the individual 
in the revised Wilson and Cleary model (Ferrans et al., 2005). The current literature on 
quality of life in persons with ESRD is not clear on how these variables impact quality of 
life.  There are varying results regarding outcomes, and often measures of health status 
43                
 
were used to quantify quality of life rather than a more holistic quality of life instrument.  
Thus, examining age, gender, and race/ethnicity using a holistic quality of life measure 
will add new knowledge regarding quality of life in persons with ESRD. 
Characteristics of the Environment 
The environment, which includes both social interactions as well as physical 
surroundings, influences one’s perception of quality of life (Ferrans et al., 2005).  Like 
the characteristics of the individual, characteristics of the environment impact all 
antecedents of quality of life.  Therefore, characteristics of the environment are important 
to include in quality of life research.  Studies with persons with ESRD have examined 
marital status, socioeconomic status, and time on hemodialysis as important 
environmental factors.   
Marital status implies the presence or absence of a fulfilling human relationship 
with a supportive partner who can also be relied upon for assistance with activities of 
daily living.  Both the emotional and practical aspects of a long term partnership have 
implications for quality of life.  Quality of life studies involving persons with ESRD have 
had mixed results with regard to marital status.  One study found that married persons 
with chronic kidney disease, both pre-dialysis and after dialysis initiation, had a 
significantly higher quality of life than non-married persons (Frank et al., 2003).  Another 
study using a large international database of 9,526 persons with ESRD found that married 
patients had significantly lower scores for sexual function and effects of kidney disease 
on daily life (Lopes et al., 2007).  The investigators did not provide a possible rationale 
for this finding.  Two other studies found that marital status did not have a significant 
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effect on quality of life (Ferrans & Powers, 1993; Morsch et al., 2006).  The study by 
Ferrans and Powers used a mailed survey to measure quality of life.  This design may 
have been biased towards respondents with a higher quality of life who could 
independently complete the survey, or who had a spouse that could assist.  Those not 
married and/or with a poorer quality of life may not have been as able to complete the 
survey.  The study by Morsch et al. defined marital status as “living alone” or “living 
with someone.” This dichotomous definition of marital status may not have captured the 
emotional bond associated with a committed, marital relationship.  Therefore, marital 
status warrants further investigation within the ESRD population as it relates to quality of 
life.   
Socioeconomic status is another characteristic of the environment that may 
influence quality of life.  Persons living below poverty levels are often not able to afford 
adequate housing, transportation, food, and medications that can positively impact quality 
of life.  In addition, poverty is often associated with other environmental concerns such as 
polluted neighborhoods and substandard housing (Bullard, 2002).  Studies that have 
examined the impact of socioeconomic status (SES) of the quality of life of persons with 
ESRD report varied results.  One study found that SES was positively correlated with 
quality of life, explaining between 5.5% and 14.1% of the variation in quality of life 
dimensions (Sesso et al., 2003).  Another study reported that unemployment was 
significantly correlated with quality of life, and lower income was associated with lower 
mental component scores of the SF-36 (Lopes et al., 2007).  However, two other studies 
reported that SES was not significantly correlated with quality of life (Ferrans & Powers, 
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1993; Frank et al., 2003).  Although Ferrans and Powers did not find a significant 
relationship between income and quality of life, they did report a significant relationship 
between employment status and quality of life.  Frank et al. (2003) did not provide a 
possible explanation for the lack of correlation between quality of life and SES.  
However, their study used the SF-36 which may have been a limited measure of quality 
of life.  Because most persons with ESRD qualify for Medicare benefits, they usually 
receive similar health care independent of SES status.  Therefore, a quality of life 
measure would need to measure quality of life more holistically than the SF-36 to capture 
differences in quality of life.  Consequently, more research is needed to understand the 
impact of SES on a holistic conceptualization of quality of life.   
Time on dialysis is the final characteristic of the environment that is an important 
variable to examine in quality of life studies.  Persons on hemodialysis often anecdotally 
report a honeymoon phase following the initiation of hemodialysis due to a reduction in 
uremic symptoms.  However, over time, the illness trajectory of persons with ESRD is 
portrayed as periods of stability interspersed with downward progression of the disease 
(Jablonski, 2004).  Thus, according to this conceptualization, persons who have been on 
hemodialysis for a long time will experience an overall reduction in health.  In addition, 
the longer a person has been on hemodialysis, the longer he or she has been immersed 
within the dialysis clinic culture, a highly technical, medicalized environment.  This 
clinical environment is a constant reminder of disease and infirmity.  Few studies of 
quality of life and ESRD have included time on hemodialysis as an independent variable.  
Two studies found no correlation between time on dialysis and quality of life (Ferrans & 
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Powers, 1993; Jablonski, 2007).  However, another study comparing quality of life at the 
onset of hemodialysis and one year later, found that patients who had been undergoing 
hemodialysis for more than a year reported a higher quality of life (Morsch et al., 2006). 
Likewise, Walters et al. (2002) found that persons who had been on hemodialysis for a 
longer period of time reported a higher quality of life than persons who were new to 
hemodialysis.   Both studies used the SF-36 (Walters et al. used the KDQOL-36) to 
measure quality of life which may indicate an improvement in uremic symptoms rather 
than an improvement in overall quality of life.  Further study is needed to understand how 
time on dialysis affects overall quality of life.   
Marital status, SES, and time on dialysis are examples of characteristics of the 
environment in the revised Wilson and Cleary model (Ferrans et al., 2005).  The findings 
of current studies with persons who have ESRD provide conflicting evidence of the 
impact of these variables on quality of life.  As seen in many studies, the SF-36 was a 
commonly used instrument to measure quality of life, which is a better measure of health 
status than quality of life.  Therefore, further research is needed as to which 
environmental characteristics most impact overall quality of life.   
Summary 
Many studies have examined quality of life in persons with ESRD.  However, 
only two used a conceptual model that clearly delineated the antecedents of quality of life 
(Ferrans & Powers, 1993; Frank et al., 2003).  Frank et al. used Wilson and Cleary’s 
depiction of health-related quality of life and Ferrans and Powers used the domains 
identified from a factor analysis of their Quality of Life Index.  No studies have been 
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published using the revised Wilson and Cleary model (Ferrans et al., 2005), which was 
expanded to include a more holistic conceptualization of quality of life.  In addition, no 
studies have been done which comprehensively analyze biological function, symptoms, 
functional status, general health perceptions, and various characteristics of the individual 
and environment.  A study by Frank et al. (2003) used the original Wilson and Cleary 
model and included all of the variables reviewed except functional status.  However, they 
used the SF-36 to measure quality of life, not a holistic instrument.  Studies which used a 
more holistic measure of quality of life (Bihl et al., 1988; Ferrans & Powers, 1993; 
Greene, 2005; Jablonski, 2007; Laws et al., 2000) did not articulate a holistic conceptual 
framework to guide their study variables, thus limiting the independent variables used to 
explain quality of life.  Therefore, a study is needed to fill these gaps in knowledge. 
Quality of life research with persons with ESRD has mainly focused on health-
related quality of life, which might best be described as health status.  This narrow 
conceptualization has left a gap in our understanding of quality of life for persons with 
ESRD and its influencing factors.  Studies are needed that use a quality of life conceptual 
framework which incorporate important health-related factors, as well as individual and 
environmental characteristics which include a broad, holistic approach.  Understanding 
quality of life through this holistic lens will add to our understanding of the quality of life 
for persons with ESRD.   
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CHAPTER III 
 
METHODS 
 
 
Design 
 
This non-experimental research study employed a cross-sectional, correlational 
design to determine factors affecting quality of life in persons on hemodialysis.   A cross-
sectional design examines data at one point in time and is best used to describe the status 
of phenomena and/ or the relationships among phenomena (Polit & Beck, 2008).  Data 
were collected one time from participants to describe their current level of quality of life, 
as well as factors affecting their quality of life.  This design was appropriate because the 
study did not look at changes in quality of life over time.   
A correlational design was also used.  A correlational design examines 
interrelationships or associations among variables that cannot be manipulated (Polit & 
Beck, 2008).  This approach was suitable for the study because none of the independent 
variables (biological function, symptoms, functional status, general health perceptions, 
age, gender, race/ ethnicity, time on dialysis, marital status, or socioeconomic status) 
could be logistically or ethically manipulated.   
Setting 
The data collection took place in a free-standing, outpatient dialysis clinic located 
in central North Carolina.  This clinic is one of five dialysis centers operated by the same 
national, for-profit company located within the county.  Among the five clinics, there are 
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over 500 persons on hemodialysis.  The clinic used for data collection is the largest of the 
five, and currently has 157 persons regularly attending in-patient hemodialysis.  The 
medical care at all the centers is managed by nephrologists working within the same 
private practice.   
Sample 
A convenience sampling design was used to obtain participants from the 
outpatient dialysis clinic.  Inclusion criteria consisted of:  (a) persons actively undergoing 
in-center hemodialysis, (b) on hemodialysis for at least three months, (c) at least 18 years 
of age or older, and (d) able to speak and understand the English language.  Exclusion 
criteria consisted of:  (a) a diagnosis of dementia or other condition which may impair the 
ability to answer questions, and (b) cognitive or medical changes occurring during the 
hemodialysis treatment that prevented the person from answering questions.   
Eligible persons at the dialysis center were approached by the charge nurse 
regarding their interest in participating.  A letter explaining the study was provided to 
each eligible, interested person.  The letter briefly explained the purpose of the study and 
indicated the time involvement. The letter was written on a fifth grade reading level with 
14-point font to assist with readability.  All participants receiving a recruitment letter 
were approached by the investigator to answer questions and obtain consent.  This 
process continued until an appropriate sample size was recruited. All participants were 
recruited from one dialysis center.  This dialysis center is located in the center of a 
metropolitan area and serves persons of various socioeconomic statuses and races.  
Confining participants to one center minimized disruption to patient care and facilitated 
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the research process by limiting persons needed to assist the investigator.  Although 
individuals typically attend the dialysis center closest to their home, it is expected that a 
representative sample from the county was obtained because each facility is very similar 
in ownership, policies and procedures, patient demographics, and local hospital and 
community resources.   
A power analysis was conducted using nQuery Advisor software to determine the 
needed sample size to answer the research questions.  For multiple linear regression, with 
a significance level of 0.05, 80% power, 15 predictor variables, and an estimated 
moderate effect size (R2 = 0.25), 70 subjects were needed.  A conservative R2 was 
estimated from a study using the Quality of Life Index- Dialysis version with persons on 
hemodialysis, in which the R2  was reported as 0.28 (Jablonski, 2007).  
Human Subjects Protection 
The study was approved by the Institutional Review Board (IRB) of The 
University of North Carolina at Greensboro.  In addition, permission to conduct the study 
at the dialysis clinic was obtained from Fresenius Medical Care’s Department of Clinical 
Studies according to corporate policy.     
All participants were fully informed regarding the purpose of the study and 
expectations of participation.  A written consent form was reviewed and signed by each 
participant prior to collecting data and each participant received a copy.  The consent 
form was written at a fifth grade reading level and clearly stated that participation was 
completely voluntary, including a statement that withdrawal from the study was 
permitted at any time without negative consequences.  In addition, a HIPAA form 
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required by the dialysis center was signed by each participant allowing access to medical 
records kept at the center. 
Confidentiality was maintained on all data collection forms by using codes to 
identify participants instead of names, medical record numbers, social security numbers, 
or any other personal identifiers.  A master list of participant names was kept separate 
from the data collection forms.  This master list was used during the data collection 
period to ensure that persons were not recruited more than once.  All data collection 
forms are kept in a locked file in the investigator’s office separate from the master list.  
Computer files pertaining to the study only use participant codes as identifiers.   
Instruments 
Eight instruments were used to collect data:  (a) the Dialysis Demographic Form, 
(b) the Dialysis Symptom Index, (c) the Hospital Anxiety and Depression Scale, (d) a 
Fatigue Visual Analog Scale, (e) the Inventory of Functional Status- Dialysis, (f) the 
Palliative Performance Scale, (g) the Global Question of General Health Perception, and 
(h) the Quality of Life Index- Dialysis Version.   
Dialysis Demographic Form.  The Dialysis Demographic Form, an investigator-
designed form, was used to collect information not captured on the other instruments (see 
Appendix A).  It included characteristics of the individual (age, gender, and race), 
characteristics of the environment (time on hemodialysis, marital status, and 
socioeconomic status), and most recent serum albumin and hemoglobin levels.  Section A 
of the Dialysis Demographic Form was completed by the investigator, and included 
information that could be extracted from the medical records kept at the dialysis center.  
52                
 
Section B of the Dialysis Demographic Form included questions to be asked of the 
participant, such as race/ ethnicity, marital status, and socioeconomic status (SES).  These 
variables are not usually in the medical record or may not be accurate.  To determine 
SES, the participant was asked to examine a chart indicating the number of people in the 
household, cross-referenced with household incomes indicating poverty.  This chart 
reflects the poverty guidelines updated periodically in the Federal Register by the U.S. 
Department of Health and Human Services (2007) under the authority of 42 U.S.C. 
9902(2).  The participant was asked, “Is your household income more than the indicated 
amount for the number of people in your home?”   
Dialysis Symptom Index.  Most studies that have explored symptoms experienced 
by persons on dialysis have used either a general symptom scale imbedded within a larger 
instrument, such as the SF-36 (Thomas-Hawkins, 2000; Weisbord et al., 2003) or the 
investigators generated their own tool of dialysis symptoms for the purposes of the study 
(Curtin, Bultman, et al., 2002; Jablonski, 2007; Merkus et al., 1999).  The problem with 
using a general symptom scale is that the unique symptoms experienced by persons on 
dialysis are often not addressed.  The problem with investigator-generated tools for 
specific studies is that they are often not accessible to other researchers, vary 
considerably in the number and dimensions of symptoms measured, and may not have 
been subjected to rigorous reliability and validity testing.   
The Dialysis Symptom Index (DSI) is a comprehensive instrument which 
measures 30 common physical and emotional symptoms experienced by persons on 
hemodialysis, and the severity/ frequency of those symptoms (see Appendix B) 
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(Weisbord et al., 2004).  The participant was asked if a symptom was experienced during 
the past week.  If yes, the participant was asked to what degree it was bothersome on a 
five-point scale, with 1 = not at all, and 5 = very much.  The responses on the severity 
dimension were added together for a total symptom severity score.   
The DSI was created in four phases.  During phase one, general symptom indices 
that had been used in previous research with persons on hemodialysis were identified and 
the symptoms extracted for analysis.  These indices included four subscales within 
health-related quality of life questionnaires, one pre-hemodialysis symptom index, and a 
cancer symptom index.  During phase two, three focus groups were held to determine 
symptoms experienced by persons on dialysis—two with persons on hemodialysis, and 
one with renal providers.  These focus groups were audiotaped and transcribed verbatim.  
Forty-four symptoms were identified from these sessions.  After the first two phases, a 
total of 75 symptoms were identified.  Each symptom was tallied for the number of times 
it appeared in symptom indices or focus group transcripts.  Any symptom appearing four 
or more times was included in the initial DSI.  This cut-point was a subjective decision 
by the developers of the tool.  Forty-seven symptoms met this criterion.  Several 
symptoms overlapped and were combined, such as “lack of strength” and “weakness.”  
This process resulted in 34 separate symptoms.  During phase three, eight content experts 
completed content validity surveys.  Four items were discarded and seven were reworded 
which resulted in a 30-item instrument.  Convergent evidence for construct validity was 
later obtained for this new symptom instrument by significantly correlating symptom 
burden with the related construct, quality of life (Weisbord et al., 2005).   
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During the final phase of instrument development, test-retest reliability was 
conducted with 20 persons on hemodialysis, 4-7 days apart.  The percent total agreement 
was high (M = 0.80, SD = 0.09).  Most items had acceptable kappa statistics, except for 
three.  Acceptable kappa levels are generally agreed to be 0.60 or higher (Polit & Beck, 
2008).  Diarrhea (kappa = 0.06) and dizziness/ lightheadedness (kappa = 0.12) are both 
transient symptoms and the low kappa values were expected.  The researchers were 
unsure why the third symptom, ability to concentrate (kappa = 0.12), also received a low 
kappa value.  The overall kappa statistic for the entire tool was 0.48, SD = 0.22, due to 
the transient symptoms.   
Hospital Anxiety and Depression Scale.  The Hospital Anxiety and Depression 
Scale (HADS) (see Appendix C) was developed as a short tool to identify patients at risk 
for two common psychological disorders—anxiety and depression (Zigmund & Snaith, 
1983).  Since its introduction, it has been used in over 745 published papers (Bjelland, 
Dahl, Haug, & Neckelmann, 2002).  The HADS has 14 items—seven related to anxiety 
and seven related to depression.  Each item is a statement to which respondents choose 
the degree to which the statement is true for them on a four-point Likert type scale, from 
0-3, with 0 representing no symptoms, and 3 representing the clear presence of symptoms 
related to anxiety or depression.  The two subscales (HADS-A and HADS-D) are 
summed separately and may also be added together for a total score.  The cut-off score 
for determining the presence of anxiety or depression is eight for each subscale (Bjelland 
et al., 2002).   
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Concurrent validity has been reported in several studies.  When the HADS was 
administered to 50 people who had been previously diagnosed with anxiety or 
depression, the cut-off points were the same for each subscale, with only one false 
positive for each subscale (Zigmund & Snaith, 1983).  In a literature review of the 
HADS, Bjelland et al. (2002) found that six studies reported positive correlations 
between the HADS-D and Beck’s Depression Inventory which ranged from 0.62-0.73.  In 
two other studies, correlations between the HADS-A and the Clinical Anxiety Scale were 
0.69 and 0.75 (Bjelland et al., 2002).  In addition, correlations between the HADS-A and 
Spielberger’s State-Trait Anxiety Inventory ranged from 0.64-0.81 (Bjelland et al., 2002).   
 Construct validity was tested by the authors of the HADS (Zigmund & Snaith, 
1983).  Patients were asked to complete the HADS and a clinical psychologist also 
completed the HADS for each patient following a clinical interview.  Patients who were 
determined by the psychologist to be anxious, had scores that correlated well with the 
HADS-A (r = 0.54) but not the HADS-D (r = 0.08).  Similarly, patients who were 
determined to be depressed by the psychologist, had scores that correlated well with the 
HADS-D (r = 0.79) but not the HADS-A (r = 0.19).  Although patients often have 
dimensions of both depression and anxiety, the authors demonstrated that they are 
separate and different aspects of mood disorder. 
Factorial validity was documented by Bjelland et al. (2002) who found that of 19 
studies using the HADS, 11 achieved a 2-factor structure that was stable across different 
clinical populations and genders.  In addition, 21 studies using the HADS had a mean 
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Pearson correlation coefficient between the two subscales of 0.56, demonstrating that the 
two subscales are related but different constructs (Bjelland et al., 2002).   
The authors of the HADS evaluated the internal consistency of both subscales by 
correlating each item with its corresponding subscale score (Zigmund & Snaith, 1983).  
Correlations for the HADS-A ranged from 0.41-0.76 (p < 0.01), and for the HADS-D, 
correlations ranged from 0.30-0.60 (p = 0.02).  Since then, internal consistency has been 
reported in the literature to be much higher.  In an analysis of 15 studies using the HADS, 
the anxiety subscale correlations ranged from 0.68-0.93, and the depression subscale 
correlations ranged from 0.67-0.90 (Bjelland et al., 2002).   
Fatigue Visual Analog Scale.  Visual analog scales (VAS) are used to measure 
subjective experiences (Polit & Beck, 2008).  They usually consist of a 100 mm line 
anchored at both ends with perpendicular lines indicating extreme instances of the 
concept being measured.  The participant is asked to mark a point on the line indicating 
their subjective experience of the concept.  A measurement is then taken from one end of 
the scale to the participant’s mark, providing a score for that item.   
A VAS was used to measure fatigue in this study (see Appendix D).  The left 
VAS anchor indicated “no fatigue” and the right anchor indicated “severe fatigue.”  
Measurements were made from the “no fatigue” anchor to the participant’s mark.  Thus, 
the higher the number, the worse the fatigue.  Participants with no fatigue were asked to 
circle the left anchor.  Participants with severe fatigue were instructed to circle the right 
anchor.  It is a quick, simple tool to complete and has correlated well with longer 
instruments, including Belza’s Multi-dimensional Assessment of Fatigue scale (r = 0.80), 
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the vitality subscale from the SF-36 (r = 0.71), and the Brief Fatigue Inventory (r = 0.76) 
(Wolfe, 2004).   
Inventory of Functional Status- Dialysis.  The Inventory of Functional Status- 
Dialysis (IFS-D) (see Appendix E) was developed and tested specifically for persons on 
dialysis (Thomas-Hawkins, 2004).  It is derived from the Roy Adaptation Model (RAM) 
and has 17 activities divided into three subscales—personal care activities, household 
activities, and social/ community activities—which align with the primary, secondary and 
tertiary role functions of the RAM.  This scale measures the actual activities that persons 
engage in, not the activities that they can engage in.  The participant must rate each 
activity in the subscales according to the degree of participation in a typical week in the 
past month on a four-point scale:  1 = did not do, 2 = did with a lot of help, 3 = did with 
some help, 4 =did by myself.  Points are given for each activity and averaged to 
determine an overall functional status score, ranging from 1.00 to 4.00.  A higher score 
indicates a higher level of functioning.   
Content validity is supported through the tool’s use of items originating from the 
Comprehensive Inventory of Functioning, a RAM-based instrument.  In addition, items 
were also developed from clinical observations of dialysis patients as well as suggestions 
from dialysis patients.  Fifteen dialysis patients reviewed the tool, and Popham’s average 
congruency procedure was used to further establish content validity.  This procedure 
measures the average percent of agreement by content validity judges who must decide if 
the questionnaire items measure the concept being studied (Thomas-Hawkins, 2004).  
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Eight items were deleted during this process, and the final tool had a content validity 
average congruency of 90%.   
The IFS-D has also undergone construct validity testing (Thomas-Hawkins, 
2004).  Confirmatory factor analysis determined that each item was significantly related 
to its respective subscale latent variable.  Loadings by subscale ranged from 0.44-0.84 
and the relative χ2  = 2.0, indicating a good fit of the measurement model to the data.  
Correlation coefficients ranged from 0.28-0.54 demonstrating that the scales were related 
but independent.  Correlations were also conducted between the IFS-D and the Karnofsky 
Performance Status scale, a generic measure of functional ability, and the physical, role, 
and social function subscales of the SF-36.  Correlations ranged between 0.27-0.55 
indicating that the IFS-D was measuring a similar but distinct concept.  Some distinctions 
include the fact that the IFS-D measures actual participation in activities, the KPS 
measures functional ability, and the SF-36 measures the impact of health on functioning.  
In a contrasted groups approach to determining construct validity, the IFS-D was given to 
both older and younger patients on dialysis with the expectation that older persons would 
report a lower level of actual function than younger persons.  As expected, a significant, 
negative correlation was found (r = -0.49, p < 0.01) (Thomas-Hawkins, 2004).   
 The IFS-D also has good reliability statistics.  Alpha reliability for the total scale 
score was 0.88, and subscale reliabilities ranged from 0.75-0.85 (Thomas-Hawkins, 
2004).  Coefficients of 0.70 and above are considered adequate indicators of internal 
consistency (Polit & Beck, 2008).   
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Palliative Performance Scale.  The Palliative Performance Scale (PPS) (Anderson 
et al., 1996), a modification of the Karnofsky Performance Scale (KPS), measures the 
decline in function seen in terminal patients as they approach death (see Appendix F).  
The index ranges from 100% (normal, no evidence of disease) to 0% (deceased).  The 
scale progresses in 10% increments within these two anchors to describe overall level of 
function.  Persons are classified against five categories: ambulation, activity/ evidence of 
disease, self-care, intake, and level of consciousness according to descriptors for each 
percentage from 0-100.  In the event that someone does not align at the same percentage 
across the categories, the categories on the left of the scale carry more weight and should 
take precedence in determining an overall score.  The improvements made to the KPS 
which resulted in the PPS include more specific descriptions of the five categories for 
classifying functional decline, as well as the deletion of requirements for hospitalization, 
as patients often have other non-hospital options at the end of life. 
The PPS was developed for prognostication purposes, research, and program 
planning related to palliative care needs (Anderson et al., 1996).  Its predecessor, the 
KPS, has been used as a measure of function in studies involving persons with ESRD 
(Laws et al., 2000; Patel et al., 2002). Although the more up-to-date PPS has not been 
used in studies involving persons with ESRD, it may prove to be a useful measure for 
determining functional decline in this population as it relates to quality of life.  For future 
studies, it may possibly help identify stages along the chronic illness trajectory, including 
the terminal phase.     
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Because the PPS was designed to predict death, evidence of construct validity has 
focused on its prognostic properties.  In the original testing of the instrument, the authors 
found that patients with a PPS score of 10% had an average time to death of 1.88 days, 
20% had 2.62 days, 30% had 6.7 days, 40% had 10.3 days, and 50% had 13.87 days 
(Anderson et al., 1996).  Since this study, others have also validated its ability to predict 
death.  Morita, Tsunoda, Inoue, and Chihara (1999) found that patients with a PPS score 
between 30-50% survived significantly longer than patients with a PPS score of 10-20%, 
and patients with a PPS of 60-100% survived significantly longer than all others.  Virik 
and Glare (2002) found that 90% of patients with a PPS score of 10% when in the 
hospital did not survive the admission, while every patient with a PPS score of 70% or 
above did survive.  Survival analysis verified that survival curves were longer as the PPS 
score increased.  Lau, Downing, Lesperance, Shaw, and Kuziemsky (2006) also verified 
that PPS scores 10% through 50% had distinct survival curves.  Harrold et al. (2005) 
found that the PPS was a strong predictor of mortality (p < 0.001) in patients with cancer 
and non-cancer diagnoses, including ESRD.  Kring and Crane (2007) found that in a pilot 
study examining the ability of various demographic, physiological, and functional 
variables to predict death in hospitalized persons with ESRD, the PPS was significantly 
lower at the death admission than the admission immediately prior to the death 
admission. Convergent validity was established by correlating the PPS with its 
predecessor, the KPS (r = 0.94) (Morita et al., 1999).    
Reliability has not been as well documented as validity.  However, one study 
reported good interrater reliability with quadratically weighted kappa = 0.67 (p < 0.001) 
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(Harrold et al., 2005).  A kappa value of 0.60 is considered minimally acceptable (Polit & 
Beck, 2008).   
General Health Perceptions.  General health perception (see Appendix G) is often 
measured with one global question that allows the individual to synthesize all objective 
and subjective experiences regarding their personal health (Wilson & Cleary, 1995).  This 
factor was measured by one item, “How would you rate your health on a scale from 1 to 
10, with 1 = poor and 10 = excellent?” as recommended by Ferrans et al. (2005).   
Quality of Life Index- Dialysis.  The Quality of Life Index- Dialysis Version III 
(QLI-D) (see Appendix H) is a subjective, self-report measure comprised of 34 pairs of 
questions (Ferrans & Powers, 1985).  Thirty-two items make up the core version of the 
QLI and assess health care, physical health and functioning, occupation, education, 
leisure, the future, peace of mind, personal faith, life goals, personal appearance, self-
acceptance, general happiness, and general satisfaction.  Two additional questions are 
included in the QLI-D which assess life changes due to kidney failure and the possibility 
of a kidney transplant. For each pair of questions, the first item asks the degree to which 
individuals are satisfied with a certain aspect of their life, and is measured on a 6-point 
Likert-type scale with 1 = very dissatisfied, and 6 = very satisfied.  The second item asks 
the level of importance of that aspect of their life, and is also measured on a 6-point 
Likert-type scale with 1 = very unimportant, and 6 = very important.  The satisfaction 
scores are recoded and weighted according to the importance scores to determine an 
overall quality of life score.  Possible range for the final score is 0 to 30, with higher 
scores indicating a higher overall quality of life.  Thus, the QLI-D accommodates the 
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relative significance of every item, making it a value-specific and individualized 
instrument (Ferrans, 1996).  The instrument’s structure flows directly from the author’s 
definition of quality of life which states that “a person’s sense of well-being . . . stems 
from satisfaction or dissatisfaction with the areas of life that are important to him/ her” 
(Ferrans, 1996, p. 296).   
The QLI-D was an ideal instrument for this study for three important reasons.  
First, it is a self-report measure.  Using a self-report measure for quality of life is 
important because nurses often rate patients’ quality of life lower than patients rate 
themselves, and physicians tend to rate patients’ quality of life higher than patients do 
(Phillips et al., 2001).  Second, it is specific to persons on dialysis.  Global measures of 
quality of life may not include the unique life style changes required of persons with 
kidney disease, thereby overestimating perceived quality of life (Phillips et al., 2001).  
Finally, the QLI-D is a holistic measure of quality of life.  It includes not only a health 
and functioning domain, but also psychological/ spiritual, socioeconomic, and family 
domains (Ferrans, 1996).  The scale’s multi-dimensionality produces separate subscale 
scores which allow further statistical analysis regarding the effect of individual and 
combined factors on various domains of quality of life.  The impact of health on the 
various domains is not included in the scale (as is the case with the SF-36), thus making it 
an overall quality of life index, not a “health-related” quality of life index nor a “health 
status” index.   
Content validity for the QLI-D was established by constructing items based on a 
comprehensive literature review related to quality of life, as well as analyzing the 
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responses of persons on dialysis to open-ended questions regarding quality of life 
(Ferrans & Powers, 1985; Ferrans & Powers, 1993).  Construct validity was supported 
through a factor analysis which revealed four separate domains explaining 91% of the 
total variance in quality of life (Ferrans & Powers, 1993).  These domains include health 
and functioning, socioeconomic, psychological/ spiritual, and family.  In addition, when 
participants were divided into high and low socioeconomic groups, a significant 
difference was found in the socioeconomic subscale (Ferrans & Powers, 1992).  When 
participants were divided into groups based on severity of symptoms, those with less 
pain, less depression, or who were coping better with stress had significantly higher 
quality of life scores (Ferrans, 1990).  To support convergent validity, the QLI (generic 
version) has been correlated with a single-item life satisfaction assessment across several 
studies.  This single-item measure was developed from the work of Campbell, Converse, 
and Rodgers (1976) and asks how generally satisfied an individual is with life.  
Correlations between the QLI and life satisfaction scores range from 0.61-0.93 across 
seven studies (Ferrans, 2006).  The correlation between the QLI-D and life satisfaction 
was 0.65 with persons on dialysis (Ferrans & Powers, 1992).    
Reliability of the QLI has been well established.  In the initial testing of the 
generic instrument, Cronbach’s alpha was 0.93 for graduate students, and 0.90 for 
dialysis patients (Ferrans & Powers, 1985).  Test-retest statistics were 0.87 after two 
weeks for graduate students, and 0.81 after one month for dialysis patients (Ferrans & 
Powers, 1985).  Across 48 studies involving persons of varying diagnoses, Cronbach’s 
alpha has ranged from 0.73 - 0.99, and 0.88 - 0.93 for persons on dialysis (Ferrans, 2006).   
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Procedures 
The principal investigator (PI) educated the charge nurse from the participating 
dialysis center regarding the study purpose and data collection methods.  The charge 
nurse approached all eligible persons regarding the study to obtain an initial 
determination of interest.  The charge nurse gave all interested participants a letter from 
the PI describing the study in more detail, including specific subject requirements.  This 
letter was written at a fifth grade reading level in 14-point font to assist with readability.  
The PI or a Research Assistant (RA) approached all eligible, interested participants 
during a routine dialysis session to answer questions and obtain written consent, 
including a HIPAA waiver required by the dialysis center.   
The PI trained one RA to assist with data collection.  The RA was a registered 
nurse familiar with care of persons on dialysis.  Training included screening for 
eligibility, human subject protection, how to complete data instruments, data collection 
procedures to maintain reliability, data management to maintain integrity and 
confidentiality, and managing cognitive changes or fatigue during data collection.  The 
RA observed two simulated data collection sessions by the PI, and then the PI and RA 
simultaneously recorded data on each instrument with two separate simulated subjects.  
Simultaneous data collection continued in this controlled environment until an interrater 
reliability score of >0.90 was obtained on each measure.   The PI collected data on 37% 
of the participants, and the RA collected data on the remaining 63%.     
Participants completed the study instruments during a routine dialysis session.  
Data collection did not occur until the person had been on dialysis for at least 60 minutes.  
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This lag time prevented data collection during a potentially unstable time of hemodialysis 
when fluid and electrolyte shifts are greatest and individuals are prone to cognitive 
changes.  Participants were asked to complete eight instruments:  (a) the Dialysis 
Demographic Form—part B, (b) the Dialysis Symptom Index, (c) the Hospital Anxiety 
and Depression Scale, (d) a Fatigue VAS, (e) the Inventory of Functional Status—
Dialysis, (f) the Palliative Performance Scale, (g) the General Health Perception Survey, 
and (h) the Quality of Life Index—Dialysis version III.  The instruments were read to the 
participants in an interview fashion.  Response scales, but not the questions, were given 
to the participants to refer to during the interview.  This strategy eliminated bias due to 
literacy levels, allowed the participant to ask clarifying questions during data collection, 
and provided a visual cue for accurate responses.  Participants who were willing to 
participate but were uncomfortable with the interview method completed the study 
instruments independently if deemed cognitively intact by regular dialysis personnel.  It 
was anticipated that completion of all eight instruments would take approximately 60 
minutes, however the average completion time anecdotally was reported to be closer to 
30 minutes.  If participants were unable to complete all instruments during one session, 
data collection continued at the next scheduled dialysis session, or within one week.  
Only one participant completed the instruments in two separate sessions.  The 
instruments were administered in rotating order to decrease bias due to response fatigue. 
Each study instrument was completed in its original format, except for the PPS.  
The PPS is usually completed by a health care provider in collaboration with the patient 
or family.  It involves some subjectivity on the part of the person computing the final 
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percentage.  For this reason, the PPS was reformatted during data collection to facilitate 
ease in selecting responses (see Appendix F).  Each question had only one best response 
which was recorded on the reformatted tool by either the PI or RA.  At a later time, these 
responses were transferred by the PI onto the original PPS form and a percentage 
determined by the PI.  No other person was involved in calculation of the PPS 
percentage.   
Participants received a thank you letter from the PI and a ten dollar bill 
immediately following completion of all instruments as a token of appreciation for their 
time and willingness to share their experiences.   
Data Analyses Plan 
Descriptive statistics were calculated for each variable.  Mean, standard deviation, 
range, skewness and kurtosis were determined for all interval-level variables.  
Proportions were determined for each nominal-level variable.  All interval-level data that 
was not normally distributed was transformed to meet assumptions before applying 
statistical tests.   
Instrument testing was done prior to other data analyses.  Scores were calculated 
for the Dialysis Symptoms Index, Hospital Anxiety and Depression Scale, Fatigue Visual 
Analog Scale, Inventory of Functional Status- Dialysis, Palliative Performance Scale, and 
Quality of Life Index—Dialysis version III.  Cronbach’s alpha was calculated for each 
instrument.   
Data analyses for specific aims.  Data analyses for each specific aim and research 
question are outlined below.  
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Specific Aim #1:  Describe the quality of life in persons with ESRD.   
Q1:  What is the quality of life in persons with ESRD?   
To determine the quality of life in persons with ESRD, the total score of the 
Quality of Life Index- Dialysis version III was calculated for each participant.  Syntax 
developed for SPSS by the index’s author was used to recode and weight each item 
according to importance ratings.  The mean, standard deviation, minimum, and maximum 
for the total QLI-D were calculated.  In addition, subscale scores (health and functioning, 
socioeconomic, psychological/ spiritual, and family) were also calculated.   
Specific Aim #2:  Examine factors that may affect quality of life in persons with 
ESRD. 
 Q2:  Do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, and general 
health perception explain quality of life in persons with ESRD? 
 All independent variables were correlated with each other and checked for 
multicollinearity.  In the event that two variables correlated at 0.85 or higher, one 
variable would be eliminated from the multiple regression analysis or separate models 
would be created.  In addition, the tolerance level and variance inflation factor of all 
independent variables were calculated to further determine multicollinearity when all 
variables were examined together.  A tolerance value less than 0.10 and a variance 
inflation factor greater than 10 were used to identify multicollinearity for possible 
elimination of variables (Mertler & Vannatta, 2002).   
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 Extreme outliers can have an unacceptable impact on a regression solution.  
Therefore, frequency distributions were run for each variable and examined for outliers.  
In addition, multivariate outliers were detected through standardized residual values 
greater than 3.0 or less than -3.0.  Outliers would be rescored, deleted, or separate 
regression models would be created.   
 Next, all variables were checked for assumptions related to multiple regression—
multivariate normality, linearity, and homoscedasticity—by examining standardized 
residual scatterplots.  Scatterplots should reveal a rectangular form distributed equally 
along the center line.  Violations of any of the assumptions for multiple regression will 
reveal a different scatterplot shape.  In the event that any assumptions were violated, data 
would be transformed in an attempt to stabilize the variance and achieve linearity and 
normality (Polit, 1996).   
 All predictor variables were entered simultaneously into a multiple regression 
model to determine how well the main health-related variables—biological function, 
symptoms, functional status, and general health perception—explained overall quality of 
life.  Statistical significance for each variable was set at alpha = 0.05, but the overall 
model was set at alpha = 0.01.  This higher significance level for the overall model was 
chosen to prevent a Type I error due to multiple analyses.  Because three separate 
analyses using overall quality of life as the dependent variable were conducted, a 
Bonferroni correction was applied to the significance level (Polit, 1996), yielding the 
higher alpha.      
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 One point of possible concern should be addressed at this point.  Hemoglobin 
levels can vary according to gender differences and therefore are sometimes reported as 
normal or abnormal according to gender-specific and/ or menopausal guidelines 
(Williams, Crane, & Kring, 2007).  However, these differences are not prevalent in 
persons with ESRD because amenorrhea is common for women of child bearing age, and 
pregnancy is very rare (Candela & Parker, 2006).  Recent studies examining hemoglobin 
and hematocrit levels and their effect on quality of life have kept the serum values as 
continuous level variables, without adjusting for gender differences (Baiardi et al., 2002; 
Lopes et al., 2007; Morsch et al., 2006; Patel et al., 2002).  To explore the issue of 
hemoglobin and gender differences, analysis for the proposed study included a t-test for 
differences in the mean hemoglobin levels between men and women.  If no significant 
differences existed, the continuous level variable would be included in the regression 
analysis.  If differences were present, the hemoglobin levels would be recoded as 
“normal” or “abnormal” according to the National Kidney Foundation guidelines for 
anemia, which takes menopausal status into consideration (National Kidney Foundation, 
2007).  According to these guidelines, a normal hemoglobin for men and post-
menopausal women is 12.5 g/ dl or greater, and for non-menopausal women a normal 
hemoglobin is 11.0 or greater.  If recoded, hemoglobin would be entered into the 
regression equation as a dichotomous dummy variable. 
 Q3:  Do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, general health 
perception, characteristics of the individual (age, gender, race/ ethnicity), and 
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characteristics of the environment (time on dialysis, marital status, and SES status) 
explain quality of life in persons with ESRD?  
 The statistical analysis for this question was similar to the analysis done for 
question two.  Data were checked for multicollinearity, multivariate normality, linearity, 
homoscedasticity, and outliers.  All predictor variables were entered simultaneously into a 
multiple regression model to determine how well the 15 variables explained overall 
quality of life.  Statistical significance for each variable was set at alpha = 0.05 and the 
overall model was set at alpha = .01.   
 Q4:  Do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, general health 
perception, characteristics of the individual (age, gender, race/ ethnicity), and 
characteristics of the environment (time on dialysis, marital status, and SES status) 
explain dimensions of quality of life (health and functioning, socioeconomic, 
psychological/ spiritual, and family) in persons with ESRD? 
 The statistical analysis for this question was also similar to the analysis done for 
question two.  Data were checked for multicollinearity, multivariate normality, linearity, 
homoscedasticity, and outliers.  All predictor variables were entered simultaneously into 
a multiple regression model to determine how well the 15 variables explain each of the 
four domains of quality of life.  Four separate models were run, one for each domain.  
Statistical significance for each variable and the overall model was set at alpha = .05.   
 Q5:  When controlling for characteristics of the individual (age, gender, and race) 
and characteristics of the environment (marital status, socioeconomic status, and time on 
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hemodialysis), do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, and general 
health perception explain quality of life in persons with ESRD? 
 For this final analysis, data were again checked for multicollinearity, multivariate 
normality, linearity, homoscedasticity, and outliers.  Characteristics of the individual and 
characteristics of the environment were entered into the multiple regression model as the 
first block.  Then the other predictor variables were entered together as the second block.  
This analysis determined the specific amount of variance that health-related variables 
have on overall quality of life above and beyond what was explained by characteristics of 
the individual and characteristics of the environment (Mertler & Vannatta, 2002).    
Limitations 
 Several limitations to this cross-sectional study design are acknowledged.  
Because persons on dialysis typically spend 12 hours or more per week undergoing this 
therapy at a local community clinic, recruitment was most likely enhanced by allowing 
them to participate during a regularly scheduled dialysis treatment.  However, 
hemodialysis can cause dramatic swings in blood pressure and electrolytes.  Thus, they 
may not have felt their best while answering questions related to their health and overall 
feelings of well-being.  In addition, intra-dialytic cognitive changes, including decreased 
concentration and memory, have been reported (Griva et al., 2003).   These changes are 
often transient and care was taken to ensure that the person had stabilized after dialysis 
initiation before participating in the study and that ample time was provided to respond to 
questions.  A convenience sample from one county was used for the study.  Persons who 
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agreed to participate may be different from those who declined.  In addition, participants 
from this county may be different from dialysis persons in other counties, as well as other 
parts of the country.  Thus, the sampling technique may limit external validity.  In 
addition, the cross-sectional study design isolated participants’ experiences to one point 
in time.  This approach may misrepresent the dynamic nature of quality of life and its 
influencing factors. 
Summary 
A cross-sectional, correlational non-experimental study was conducted to 
determine factors affecting quality of life in persons on hemodialysis.  A targeted 
convenience sample of at least 70 persons undergoing hemodialysis at an outpatient 
dialysis center located within one city in central North Carolina was used.  The research 
study was approved by the IRB of The University of North Carolina at Greensboro, as 
well as Fresenius Medical Care’s Department of Clinical Studies.  Eight instruments were 
administered by the PI and one RA to participants while they were undergoing routine 
dialysis treatments.  Data analysis included descriptive statistics, as well as various 
multiple regression models, to determine the influence of 15 predictor variables on 
quality of life, according to the revised Wilson and Cleary model of quality of life 
(Ferrans et al., 2005).   
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CHAPTER IV 
 
RESULTS 
 
 
This chapter will describe the results of the statistical analyses.  A description of 
the final sample size is followed by an examination of study data, outcomes of instrument 
testing, demographic data, and an analysis of each separate research question.  In addition 
to the planned tests, several additional models were explored based on initial findings.   
Sample 
All the patients (N = 157) at the selected dialysis center received a recruitment 
letter from the center’s charge nurse.  Eighty-five persons were approached by the 
Principal Investigator (PI) or Research Assistant (RA) to participate.  Persons were 
approached if they were 60 minutes into their dialysis treatment, had at least 60 minutes 
remaining, and were awake.  Twelve persons did not participate: (a) seven declined with 
no reason given, (b) three persons were ineligible because they had been on dialysis for 
less than three months, (c) one person did not speak English, and (d) one person was 
unable to make informed consent due to cognitive impairment.  Only one person required 
data to be collected over two separate dialysis days due to fatigue.  All other participants 
were able to complete the study during one dialysis session. Data collection time 
typically lasted between 30-60 minutes per person.  A total of 73 persons completed the 
study. 
74                
 
Preliminary Examination of Data  
All data were entered into SPSS version 15.0.  Five instruments required 
calculation of scores.  These computations were done by creating new variables in SPSS 
using formulas to determine scale totals.  Ferrans’ syntax for the Quality of Life Index- 
Dialysis (QLI-D) was used to score the QLI-D and the four subscales.  Cronbach’s alpha 
was determined for each instrument to check for internal reliability.  Scores were 
acceptable (Gliner & Morgan, 2000) and ranged from 0.622–0.937 (see Table 1).   
 
Table 1 
Internal Reliability of Instruments 
Instrument Cronbach’s 
alpha 
 
Dialysis Symptom Index 
 
 
0.867 
Hospital Anxiety and Depression Scale-  
Total 
 
0.779 
Hospital Anxiety and Depression Scale-      
Anxiety subscale 
 
0.805 
Hospital Anxiety and Depression Scale- 
Depression subscale 
 
0.622 
Inventory of Functional Status- Dialysis 
 
0.860 
Quality of Life Index- Dialysis 
 
0.937 
 
 
 
The QLI-D required calculating the Cronbach’s alpha without item 22.  Item 22 
was to be answered by participants who were employed.  Because only 12 participants 
75                
 
were employed, resulting in a low response rate for that item, SPSS was unable to run the 
calculation with item 22 included.  Therefore, the Cronbach’s alpha was determined 
without item 22.  
To visually check for missing data and extreme values, frequencies were run on 
all variables.  There was one missing data point regarding income level.  Because this 
question was on the back of the demographic form, it was most likely overlooked during 
data collection.  One extreme value was found.  A hemoglobin value was recorded as 
37.7.  The PI questioned whether a hematocrit value had been entered instead of a 
hemoglobin level.  The charge nurse at the dialysis center was contacted by telephone 
and the correct value, 13.1, was obtained.  The errant value was replaced by the correct 
value in the database. No other extreme values were noted. 
The data were also visually examined for outliers and linearity by means of 
scatterplots which graphed each continuous independent variable against the dependent 
variable, quality of life.  One outlier was noted on the QLI-D.  Due to this finding, 
additional regression analyses were conducted to examine the results without the outlier.   
Each continuous variable was tested for normality by examining skewness and 
kurtosis statistics.  Variables were considered normally distributed if skewness and 
kurtosis values were between -1 and +1.  Three variables did not fall within this range:  
(a) time on hemodialysis, (b) serum albumin, and (c) the Family subscale of the QLI-D.  
The variable time on dialysis was positively skewed and a square root transformation was 
applied.  The variables serum albumin and Family subscale were negatively skewed.  
Before a transformation could be applied, the variables were reflected.  To reflect each 
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variable, the highest value in the distribution was determined and increased by one to 
form a constant that was higher than every value.  Each value was then subtracted from 
this constant yielding reverse scores and a positively skewed distribution.  Following 
reflection, a square root transformation was applied.  These transformations significantly 
improved both skewness and kurtosis (see Table 2).  All other continuous variables 
demonstrated skewness and kurtosis values between the acceptable range of -1 and +1.   
 
Table 2 
The Effect of Data Transformation on Skewness and Kurtosis 
 
Variable 
 
Pre-transformation 
Skewness               Kurtosis 
 
Post-transformation 
Skewness               Kurtosis 
 
 
Time on hemodialysis 
 
 
  1.734 
 
3.615 
 
0.700 
 
-0.117 
Serum albumin 
 
-1.300 4.230 0.105   1.125 
Family subscale 
 
-1.130 0.571 0.496 -0.731 
 
 
 
Characteristics of the Individual and Environment 
The sample consisted of 73 hemodialysis patients from one dialysis center.  Most 
of the participants were female (55%), African American (76%) and not married (67%).  
Over half reported household incomes above the federal poverty level (56%) and felt they 
were not likely to receive a kidney transplant (58%).  Ages ranged from 20 to 89 years 
old, with a mean age of 56 years (SD = 15.8).  Time on hemodialysis ranged from 3 
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months (the study’s minimum allowed) to 301 months (25 years) with a mean of 56 
months (SD = 58.3).  Demographic data are displayed in Table 3.   
 
Table 3 
Demographic Statistics (N = 73) 
 
Variable 
 
 
Frequency (%) 
 
Gender 
     Female 
     Male 
 
 
 
40    (55%) 
33    (45%) 
Race/ ethnicity 
     African American 
     White 
     Hispanic 
     Other 
 
 
56    (76%) 
13    (18%) 
  2    (  3%) 
  2    (  3%) 
Marital status 
     Married 
     Never married 
     Divorced/ separated 
     Widowed 
 
 
24    (33%) 
21    (29%) 
15    (20%) 
13    (18%) 
Annual family income 
     Above poverty 
     Below poverty 
     Do not know 
     Prefer not to answer 
     Missing data 
 
 
41    (56%) 
22    (30%) 
  6    (  8%) 
  3    (  4%) 
  1    (  2%) 
Likelihood of transplant 
     Not likely 
     Probably not likely 
     Somewhat likely 
     Very likely 
     I do not know 
 
 
37    (51%) 
  5    (  7%) 
  8    (11%) 
16    (22%) 
  7    (  9%) 
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Health-Related Variables 
The health-related variables in the model consisted of biological factors, 
symptoms, functional status, general health perception, and overall quality of life.  
Descriptive results of each variable are summarized in Table 4.   
 
Table 4 
Health-Related Variables (N = 73) 
 
Variable 
 
 
Mean 
 
SD 
 
Range 
 
Possible Range 
 
Serum albumin 
 
3.90 g/dL 
 
0.40 
 
2.1–4.6 
 
3.5–4.5 
(normal range) 
Serum hemoglobin 12.58 g/dL 1.67 9.4–17.8 12–16 
(normal range) 
Dialysis symptoms 
 
41.85   23.30 5–110 0–150 
Anxiety 
 
 6.52 4.27 0–18 0–21 
Depression 
 
5.36 3.16 0–15 0–21 
Fatigue 
 
43.27   27.36 0–100 0–100 
Functional status (IFS) 
 
3.00 0.65 1.47–4.00 1–4 
Functional status (PPS) 
 
75.89   13.42 50–100 0–100 
General health perception 
 
5.67 1.83 1–10 1–10 
Quality of life- overall 
     Health and functioning 
     Socioeconomic 
     Psychological/ spiritual 
     Family 
21.14 
18.92 
21.57 
22.96 
24.71 
4.87 
5.48 
5.81 
5.73 
5.40 
7.45–30.00 
4.00–30.00 
5.50–30.00 
8.50–30.00 
8.20–30.00 
0–30 
0–30 
0–30 
0–30 
0–30 
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Research Question #1 
What is the quality of life for persons on hemodialysis?   
The overall quality of life was 21.14 (SD = 4.87) out of a possible score of 30.  A 
higher score on the QLI-D indicates a higher quality of life, thus the average reported 
score is higher than the midrange value of 15.  Each subscale was also measured on a 0-
30 scale.  The health and functioning subscale was the lowest rated subscale (M = 18.92, 
SD = 5.48), followed by the socioeconomic subscale (M = 21.57, SD = 5.81), the 
psychological/ spiritual subscale (M = 22.96, SD = 5.73), and the family subscale  
(M = 24.71, SD = 5.40).     
Simple correlations were conducted to inspect the relationships between all 
continuous variables in the study (see Table 5).  Six variables significantly correlated 
with quality of life:  (a) dialysis symptoms, (b) anxiety, (c) depression, (d) fatigue,  
(e) palliative performance scale, and (f) general health perception.  These correlations 
were low to moderate in strength (Munro, 2005).  
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Table 5   
Intercorrelations of Continuous Variables (N = 73) 
 
 
Variables 1 2 3 4 5 6 7 8 9 10 11 12 
 
1.   QLI-D 
 
 
– 
 
.099 
 
-.080 
 
-.480 
** 
 
-.502 
** 
 
-.576 
** 
 
-.282 
* 
 
.172 
 
.256 
* 
 
.583 
** 
 
.180 
 
.165 
2.   Albumin 
 
 – .313 
** 
-.104 -.259 
* 
-.294 
* 
-.049 .343 
** 
.283 
* 
.198 -.197 .327 
** 
3.   Hemoglobin 
 
  – .066 -.092 .152 .107 -.283 
* 
-.303 
** 
-.097 .043 .141 
4.   DSI 
 
   – .403 
** 
.390 
** 
.394 
** 
-.067 -.241 
* 
-.465 
** 
-.159 .003 
5.   Anxiety 
 
    – .352 
** 
.085 -.019 -.076 -.244 
* 
-.400 
** 
-.208 
6.   Depression 
 
     – .325 
** 
-.350 
** 
-.281 
* 
-.394 
** 
-.001 -.352 
** 
7.   Fatigue 
 
      – -.159 -.258 
* 
-.280 
* 
-.023 -.165 
8.   IFS-D 
 
       – .695 
** 
.296 
* 
-.524 
** 
.213 
9.   PPS 
 
        – .277 
* 
-.407 
** 
.251 
* 
10. GHP 
 
         – -.024 .135 
11. Age 
 
          – -.119 
12. Time on 
dialysis 
 
           – 
 
Variables: 
QLI-D = Quality of Life Index- Dialysis 
DSI = Dialysis Symptom Index 
IFS = Inventory of Functional Status- Dialysis 
PPS = Palliative Performance Scale 
GHP = General Health Perception 
 
*    p ≤ .05 
**  p < .001 
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Research Question #2 
Do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, and general 
health perception explain quality of life in persons with ESRD?   
 Using multiple regression, the influence of the health-related factors of the revised 
Wilson and Cleary model (Ferrans et al., 2005) on quality of life was examined.  Prior to 
running the analysis, an independent t-test was conducted to test for differences between 
men and women’s hemoglobin levels.  If this test was significant, the variable would 
have been recoded as “normal” or “abnormal” according to gender-specific guidelines.  
No statistical differences between men and women’s hemoglobin values were found  
(t = -1.483, p = 0.142).  Therefore, the decision was made to include hemoglobin as a 
continuous variable in the regression analysis.   
Before examining the regression statistics, inspections for assumptions and other 
potential problems that may affect interpreting the analysis were conducted.  Initially, the 
output was examined for any issues with multicollinearity.  Bivariate correlations showed 
no strong positive or negative correlations (all were correlated less than 0.85).  In 
addition, the tolerance values were all greater than 0.10 and the variance inflation factors 
were all less than 10.0, revealing no concerns with multicollinearity (Mertler & Vannatta, 
2002).  Next, the data were checked for multivariate outliers.  All standardized residual 
values fell between -3.0 and 3.0, indicating no issues with outliers (Tabachnick & Fidell, 
2001).  Finally, the assumptions of multiple regression—multivariate normality, linearity, 
and homoscedasticity—were checked by examining a scatterplot of predicted values and 
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residuals.  The plot had points equally distributed around the midpoint, with no 
discernible patterns noted (Polit, 1996).  Therefore, all assumptions were sufficiently met.   
 To answer the research question, all nine independent variables were entered 
together as one block.  This model significantly explained 59% (R2 = 0.589; R2adj = 
0.530) of the variance in overall quality of life, F = 9.887 (9, 62), p < 0.001.  The 
significant variables contributing to the model were serum albumin (square root), anxiety, 
depression, and general health perception (see Table 6).   
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Table 6 
Multiple Regression Summary for Health-Related Variables (N = 73) 
 Standardized 
Regression 
Coefficient 
 
t 
 
p 
 
Albumin (square root) 
 
  0.206 
 
 
  2.010 
 
  0.049* 
Hemoglobin 
 
  0.071   0.720 0.474 
Dialysis Symptom Index 
 
-0.021 -0.193 0.848 
HADS- Anxiety subscale 
 
-0.297 -3.149  0.003* 
HADS- Depression subscale 
 
-0.368 -3.584  0.001* 
Fatigue VAS 
 
-0.018 -0.194 0.847 
Inventory of Functional Status- Dialysis 
 
-0.118 -0.947 0.347 
Palliative Performance Scale (PPS) 
 
  0.189   1.515 0.135 
General Health Perception 
 
  0.370   3.719 <0.001* 
R2 = 0.589 
R2adj = 0.530 
F = 9.887 
p < 0.001 
* p  < 0.05 
   
 
 
 
Research Question #3 
 Do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, general health 
perception, characteristics of the individual (age, gender, race/ ethnicity), and 
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characteristics of the environment (time on dialysis, marital status, and SES status) 
explain quality of life in persons with ESRD?   
 This question includes characteristics of the individual and environment in 
addition to the health-related variables.  Four of the nominal variables in this analysis 
(gender, race/ ethnicity, marital status, and SES status) required dummy coding prior to 
entering into the model.  These variables were coded as dichotomous variables (Munro, 
2005) according to the most frequent response.  The dummy codes are listed in Table 7.   
 
Table 7 
Dummy Coding for Nominal Variables 
 Reference Value = 1 
 
Non-reference values = 0 
 
Gender 
 
 
Female 
 
Male 
Race/ ethnicity African American White 
Hispanic 
American Indian 
Other 
Prefer not to answer 
 
Marital status Married Never married 
Divorced 
Separated 
Widowed 
Prefer not to answer 
 
Socioeconomic status Above federal poverty level Below federal poverty level 
Do not know 
Prefer not to answer 
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 The regression output was initially examined for assumptions and problems that 
might affect confidence in the results.  Bivariate correlations were less than 0.85, 
tolerance values were all greater than 0.10, and variance inflation factors were all less 
than 10.   Therefore, no problems were noted with multicollinearity.  Standardized 
residual values indicated no issues with multivariate outliers.  The scatterplot of predicted 
and residual values demonstrated that the assumptions of multiple regression were met. 
 All of the 15 independent variables were entered together as one block.  This 
model significantly explained 61% (R2 = 0.608; R2adj = 0.501) of the variance in overall 
quality of life, F = 5.693 (15, 55), p < 0.001.  The significant variables contributing to the 
model were anxiety, depression, and general health perception (see Table 8).   
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Table 8 
 
Multiple Regression Summary for All Variables on Overall Quality of Life (N = 73) 
 Standardized 
Regression 
Coefficient 
 
t 
 
p 
 
Albumin (square root) 
 
  0.151 
 
 
  1.333 
 
0.188 
Hemoglobin 
 
  0.096   0.890 0.378 
Dialysis Symptom Index 
 
  0.014   0.119 0.906 
HADS- Anxiety subscale 
 
-0.286 -2.439   0.018* 
HADS- Depression subscale 
 
-0.413 -3.645   0.001* 
Fatigue VAS 
 
-0.020 -0.198 0.844 
Inventory of Functional Status- Dialysis 
 
-0.117 -0.797 0.429 
Palliative Performance Scale (PPS) 
 
  0.230   1.671 0.100 
General Health Perception 
 
  0.363   3.303   0.002* 
Age   0.046   0.361 0.719 
 
Female gender   0.064   0.604 0.549 
 
African American race   0.043   0.455 0.651 
 
Time on hemodialysis (square root) -0.105 -1.027 0.309 
 
Married status   0.074   0.769 0.445 
 
Income above poverty -0.002 -0.018 0.986 
 
R2 = 0.608 
R2adj = 0.501 
F = 5.693 
p < 0.001 
* p < 0.05 
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Research Question #4 
Do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, general health 
perception, characteristics of the individual (age, gender, race/ ethnicity), and 
characteristics of the environment (time on dialysis, marital status, and SES status) 
explain dimensions of quality of life (health and functioning, socioeconomic, 
psychological/ spiritual, and family) in persons with ESRD?   
 To examine the total model’s influence on each of the quality of life subscales, 
four separate regression analyses were conducted.  Each regression model had a different 
dependent variable:  (a) health and functioning dimension, (b) socioeconomic dimension, 
(c) psychological/ spiritual dimension, and (d) family dimension.  The 15 independent 
variables were entered together as one block.  For all four analyses, the assumptions for 
multiple regression were met as demonstrated by residual scatterplots.  There were no 
multivariate outliers or problems with homoscedasticity. 
 Regression #1: Health and functioning dimension.  The R2 of 0.644 (R2adj = 
0.547) indicated that over half of the variability in the health and functioning dimension 
was explained by the independent variables, F = 6.628 (15, 55), p < 0.001.  The 
significant variables contributing to this model were depression and general health 
perception (see Table 9).   
 Regression #2: Socioeconomic dimension.  This model significantly explained 
50% (R2 = 0.503, R2adj = 0.368) of the variance in the socioeconomic dimension, F = 
88                
 
3.712 (15, 55), p < 0.001.  The significant variables contributing to the model were 
anxiety, depression and general health perception (see Table 10).   
 Regression #3:  Psychological/ spiritual dimension.  A significant F value of 
3.712 (15, 55), p < 0.001 indicated that the model explained 52% (R2 = 0.520, R2adj = 
0.388) of the variance in the psychological/ spiritual dimension.  The significant 
contributing variables were again anxiety, depression and general health perception (see 
Table 11).   
 Regression #4: Family dimension.  This model significantly explained 39% (R2 = 
0.385, R2adj = 0.211) of the variance in the psychological/ spiritual dimension, F = 2.210 
(15, 53), p = 0.018.  The only significant variable contributing to the model was anxiety 
(see Table 12).   
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Table 9 
 
Multiple Regression Summary for All Variables on Health and Functioning (N = 73) 
 Standardized 
Regression 
Coefficient 
 
t 
 
p 
 
Albumin (square root) 
 
 
  0.059 
 
  0.545 
 
0.588 
Hemoglobin 
 
  0.057   0.560 0.578 
Dialysis Symptom Index 
 
  0.044   0.380 0.705 
HADS- Anxiety subscale 
 
-0.201 -1.793 0.078 
HADS- Depression subscale 
 
-0.480 -4.444 <0.001* 
Fatigue VAS 
 
-0.128 -1.350 0.182 
Inventory of Functional Status- Dialysis 
 
-0.069 -0.493 0.624 
Palliative Performance Scale (PPS) 
 
  0.192   1.460 0.150 
General Health Perception 
 
  0.334   3.195   0.002* 
Age   0.022   0.181 0.857 
 
Female gender   0.045   0.440 0.662 
 
African American race   0.104   1.152 0.254 
 
Time on hemodialysis (square root) -0.087 -0.888 0.379 
 
Married status -0.008 -0.089 0.930 
 
Income above poverty -0.055 -0.543 0.589 
 
R2 = 0.644 
R2adj = 0.547 
F = 6.628 
p < 0.001 
* p < 0.05 
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Table 10 
 
Multiple Regression Summary for All Variables on Socioeconomic Dimension (N = 73) 
 Standardized 
Regression 
Coefficient 
 
t 
 
p 
 
Albumin (square root) 
 
 
  0.099 
 
  0.776 
 
0.441 
Hemoglobin 
 
  0.033   0.274 0.785 
Dialysis Symptom Index 
 
  0.061   0.449 0.655 
HADS- Anxiety subscale 
 
-0.305 -2.307   0.025* 
HADS- Depression subscale 
 
-0.296 -2.321   0.024* 
Fatigue VAS 
 
  0.012   0.104 0.918 
Inventory of Functional Status- Dialysis 
 
-0.164 -0.996 0.324 
Palliative Performance Scale (PPS) 
 
  0.250   1.614 0.112 
General Health Perception 
 
  0.282   2.284   0.026* 
Age   0.107 
  
  0.750 0.457 
Female gender   0.176   1.475 0.146 
 
African American race -0.069 -0.646 0.521 
 
Time on hemodialysis (square root) -0.177 -1.530 0.132 
 
Married status   0.149 
 
  1.372 0.176 
Income above poverty   0.160 
 
  1.329 0.189 
R2 = 0.503 
R2adj = 0.368 
F = 3.712 
p < 0.001 
* p < 0.05 
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Table 11 
 
Multiple Regression Summary for All Variables on Psychological/ Spiritual Dimension 
(N = 73) 
 
 Standardized 
Regression 
Coefficient 
 
t 
 
p 
 
Albumin (square root) 
 
 
  0.157 
 
  1.251 
 
0.216 
Hemoglobin 
 
  0.171   1.437 0.156 
Dialysis Symptom Index 
 
  0.000 -0.001 1.000 
HADS- Anxiety subscale 
 
-0.272 -2.089   0.041* 
HADS- Depression subscale 
 
-0.348 -2.772   0.008* 
Fatigue VAS 
 
  0.082   0.745 0.459 
Inventory of Functional Status- Dialysis 
 
-0.077 -0.473 0.638 
Palliative Performance Scale (PPS) 
 
  0.188   1.236 0.222 
General Health Perception 
 
  0.352   2.898   0.005* 
Age 
 
  0.102   0.729 0.469 
Female gender 
 
-0.122 -1.033 0.306 
African American race 
 
  0.071   0.678 0.501 
Time on hemodialysis (square root) 
 
-0.051 -0.451 0.654 
Married status 
 
  0.037   0.342 0.733 
Income above poverty 
 
-0.092 -0.780 0.439 
R2 = 0.520 
R2adj = 0.388 
F = 3.964 
p < 0.001 
* p < 0.05 
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Table 12 
 
Multiple Regression Summary for All Variables on Family Dimension (N = 73) 
 Standardized 
Regression 
Coefficient 
 
t 
 
P 
 
Albumin (square root) 
 
 
-0.251 
 
-1.709 
 
0.093 
Hemoglobin 
 
-0.057 -0.678 0.501 
Dialysis Symptom Index 
 
  0.126   0.819 0.417 
HADS- Anxiety subscale 
 
  0.355   2.327   0.024* 
HADS- Depression subscale 
 
  0.156   1.081 0.285 
Fatigue VAS 
 
-0.186 -1.510 0.137 
Inventory of Functional Status- Dialysis 
 
  0.183   0.982 0.331 
Palliative Performance Scale (PPS) 
 
-0.140 -0.802 0.426 
General Health Perception 
 
-0.175 -1.258 0.214 
Age 
 
  0.068   0.419 0.677 
Female gender 
 
-0.166 -1.237 0.222 
African American race 
 
-0.012 -0.096 0.924 
Time on hemodialysis (square root) 
 
  0.144   1.073 0.288 
Married status 
 
-0.191 -1.561 0.125 
Income above poverty 
 
  0.034   0.251 0.803 
R2 = 0.385 
R2adj = 0.211 
F = 2.210 
P = 0.018 
* p < 0.05 
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Research Question #5 
When controlling for characteristics of the individual (age, gender, and race) and 
characteristics of the environment (marital status, socioeconomic status, and time on 
hemodialysis), do biological function (serum albumin and serum hemoglobin), symptoms 
(dialysis symptoms, anxiety, depression, and fatigue), functional status, and general 
health perception explain quality of life in persons with ESRD? 
 Sequential regression was employed to determine if the addition of health-related 
variables to the model improved the explanation of variance in overall quality of life after 
the characteristics of the individual and the environment were already taken into account.  
Characteristics of the individual and characteristics of the environment were entered into 
the multiple regression model as the first block, and the other health-related variables 
were entered together as the second block.  The assumptions for multiple regression were 
met as demonstrated by residual scatterplots.  There were no multivariate outliers or 
problems with homoscedasticity.   
 Characteristics of the individual and environment did not significantly contribute 
to overall quality of life, F = 1.310 (6, 64), p = 0.266.  However, after controlling for 
individual and environmental characteristics, model two significantly explained 61% (R2 
= 0.608, R2adj = 0.501) of the variance in overall quality of life, F = 7.781 (9, 55), p < 
0.001.  Again, anxiety, depression, and general health perception were the only 
significant contributing variables (see Table 13). 
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 Table 14 provides a comparison of all the regression models and the resulting 
significant variables.  Post-hoc power analyses indicated that all models had 99% power 
to detect differences if such differences existed.  
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Table 13 
 
Multiple Regression Summary Controlling for the Individual and the Environment  
(N = 73)  
 
 
Model 
 Standardized 
Regression 
Coefficient 
 
t 
 
p 
 
1 
 
Age 
 
  0.202 
 
  1.561 
 
0.123 
 Female gender -0.093 -0.678 0.501 
 African American race   0.176   1.399 0.167 
 Married status   0.144   1.139 0.259 
 Income above poverty   0.086   0.624 0.535 
 Time on hemodialysis (square root)   0.110   0.905 0.369 
 
2 
 
Age 
  
  0.046 
 
  0.361 
 
0.719 
 Female gender   0.064   0.604 0.549 
 African American race   0.043   0.455 0.651 
 Married status   0.074   0.769 0.445 
 Income above poverty -0.002 -0.018 0.986 
 Time on hemodialysis (square root) -0.105 -1.027 0.309 
 Albumin (square root)   0.151   1.333 0.188 
 Hemoglobin   0.096   0.890 0.378 
 Dialysis Symptom Index   0.014   0.119 0.906 
 HADS- Anxiety subscale -0.286 -2.439   0.018* 
 HADS- Depression subscale -0.413 -3.645   0.001* 
 Fatigue VAS -0.020 -0.198 0.844 
 Inventory of Functional Status- Dialysis -0.117 -0.797 0.429 
 Palliative Performance Scale (PPS)   0.230   1.671 0.100 
 General Health Perception   0.363   3.303   0.002* 
 
1 
 
R2 = 0.109 
R2adj = 0.026 
F = 1.310 
p = 0.266 
 
   
2 R2 = 0.608 
R2adj = 0.501 
F = 7.781 
p < 0.001 
* denotes significance 
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Table 14 
A Comparison of All Multiple Regression Models (N = 73) 
Model* 1 2 3 4 5 6 7 
 
R2 
 
 
0.589 
 
0.608 
 
0.644 
 
0.503 
 
0.520 
 
0.385 
 
0.109 
0.608 
 
R2adj 
 
0.530 0.501 0.547 0.368 0.388 0.211 0.026 
0.501 
 
F 
 
9.887 5.693 6.628 3.712 3.964 2.210 1.310 
5.693 
 
p 
 
<0.001 <0.001 <0.001 <0.001 <0.001 0.018 0.266 
 <0.001 
 
Significant variables 
      
       
     Anxiety        
     Depression        
     General Health                
Perception 
       
     Albumin        
 
*Model Descriptions: 
1 = All health-related variables on overall quality of life 
2 = All variables on overall quality of life 
3 = All variables on health and functioning subscale 
4 = All variables on socioeconomic subscale 
5 = All variables on psychological/ spiritual subscale 
6 = All variables on family subscale 
7 = Controlling for characteristics of the individual and environment in block one 
 
 
 
97                
 
Additional Analyses 
After examination of the results, additional analyses were conducted based on the 
findings.  The first analysis was done to remove the one outlier case of the QLI-D and all 
the regression models were recalculated.  The second analysis examined the impact of 
only significant bivariate correlates of the QLI-D on quality of life.  The third analysis 
explored the influence of all the nonsignificant independent variables in the initial 
regression models on quality of life.  Finally, a regression analysis was conducted to 
more clearly examine anxiety and depression as concepts separate from other dialysis 
symptoms.    
Additional analysis #1: Regressions repeated without outlier (N =72).  When 
examining scatterplots of the various independent variables and the QLI-D, one case 
consistently appeared as an outlier due to the low value of the QLI-D.  This participant 
scored 7.45 on the QLI-D whereas the mean QLI-D was 21.14 (SD = 4.87).  The next 
highest QLI-D score was 11.74. The standardized score for the potential outlier was  
-2.81.  Although still within three standard deviations of the mean, this participant was 
clearly a borderline case.   
Because regression equations can be sensitive to outliers, the regression models 
were reexamined excluding the borderline case.  All regression models were rerun using 
the exact methods described earlier.  Exclusion of this one case resulted in similar results 
(see Table 15).     
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Table 15 
Comparison of Regression Results With (N = 73) and Without(N = 72) a Borderline Case 
 
Model 
 
 
R2 
 
R2adj 
 
F 
 
p 
 
1 
    With 
    Without 
 
 
 
0.589 
0.604 
 
 
0.530 
0.546 
 
 
   9.887 
10.350 
 
 
< 0.001 
< 0.001 
2 
    With 
    Without 
 
 
0.608 
0.625 
 
0.501 
0.521 
 
  5.693 
  5.999 
 
< 0.001 
< 0.001 
3 
    With 
    Without 
 
 
0.644 
0.646 
 
0.547 
0.547 
 
  6.628 
  6.562 
 
< 0.001 
< 0.001 
4 
    With 
    Without 
 
 
0.503 
0.510 
 
0.368 
0.374 
 
  3.712 
  3.743 
 
< 0.001 
< 0.001 
5 
    With 
    Without 
 
 
0.520 
0.538 
 
0.388 
0.409 
 
  3.964 
  4.186 
 
< 0.001 
< 0.001 
6 
    With 
    Without 
 
 
0.385 
0.384 
 
0.211 
0.206 
 
  2.210 
  2.158 
 
   0.018 
   0.021 
7 
    With 
       Block 1 
       Block 2 
    Without 
       Block 1 
       Block 2 
 
 
0.109 
0.608 
 
0.126 
0.625 
 
 
0.026 
0.501 
 
0.043 
0.521 
 
 
  1.310 
  5.693 
 
  1.518 
  5.999 
 
 
   0.266 
< 0.001 
 
   0.187 
<0.001 
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In the majority of the regressions conducted, the R2 and R2adj increased slightly for 
each model after omitting the borderline case.  The significant contributing variables for 
each model were identical, except for model one which regressed all health-related 
variables on quality of life.  With the borderline case included in the model, the 
significant contributing variables were: anxiety, depression, general health perception, 
and albumin.  Without the borderline case, albumin ceased to be a significant variable  
(p = 0.055). 
Additional analysis #2: Significant bivariate correlates on quality of life.  The 
statistical analysis conducted for research question #3 included 15 independent variables 
regressed on overall quality of life.  Having a large number of independent variables 
tends to overestimate the R2 (Tabachnick & Fidell, 2001).  Therefore the R2 is adjusted to 
take into account both the number of independent variables and the sample size.  To 
explore how the independent variables may contribute to quality of life, an additional 
regression analysis was conducted using only variables that were significantly correlated 
with quality of life (see Table 5).  These variables included: (a) dialysis symptoms,  
(b) anxiety, (c) depression, (d) fatigue, (e) function as measured by the Palliative 
Performance Scale, and (f) general health perception.  The R2 was higher for the original 
model (0.608) when compared to the exploratory model (0.574), indicating that the other 
variables contributed to quality of life.  However, the subsequent analysis did slightly 
improve the R2adj from 0.501 to 0.534.  The variables contributing significantly to the 
model remained the same for both the original and exploratory analyses:  (a) anxiety,  
(b) depression, and (c) general health perception.   
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Additional analysis #3: Insignificant variables on quality of life.  Three 
independent variables consistently and significantly contributed to quality of life.  To 
determine if the other variables were being obscured by these three variables, a regression 
analysis was conducted omitting the three significant variables.  Although the overall 
model was significant (p = 0.004), the R2 (0.369) and the R
2
adj (0.239) were greatly 
reduced.  Only two variables significantly contributed to the model, dialysis symptoms  
(p = 0.001) and age (p = 0.036).   
Additional analysis #4: Anxiety and depression separate from other symptoms.  
To answer the research questions, both the Dialysis Symptom Index (DSI) and the 
Hospital Anxiety and Depression Scale (HADS) were used to measure symptoms.  
Anxiety and/ or depression, as measured by the HADS, significantly contributed to every 
regression model.  The DSI also includes four questions representing anxiety and 
depression.  The DSI was modified by summing the scores after removing the following 
symptoms: (a) item 22: worrying, (b) item 23: feeling nervous, (c) item 27: feeling sad, 
and (d) item 28: feeling anxious.  A regression analysis was conducted with all 15 
independent variables entered as one block using the modified DSI.  The result of this 
regression analysis (R2 = 0.612, R2adj = 0.506) was almost identical to the original results 
(R2 = 0.608, R2adj = 0.501).  The same three variables (anxiety, depression, and general 
health perception) significantly contributed to both models.  Although the modified DSI 
was not a significant factor, the p value of this variable in the model went from 0.906 in 
the original analysis to 0.490 in this analysis.     
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Summary 
Seventy-three persons on hemodialysis were interviewed to determine overall 
quality of life, as well as factors affecting quality of life.  The participants were mostly 
African American females living above the poverty level, with a mean age of 56 and a 
mean time on hemodialysis of over four years.  The overall quality of life was 21.14, with 
the health and functioning dimension of quality of life having the lowest score and the 
family-related dimension of quality of life having the highest.  Several multiple 
regression models were used to examine which factors best explained overall quality of 
life.  When all variables were included in the model, they explained 61% of the overall 
quality of life.  Characteristics of the individual and characteristics of the environment 
did not contribute significantly to any of the models.  Health-related variables 
significantly contributing to quality of life included anxiety, depression, general health 
perception, and albumin.   
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CHAPTER V 
 
DISCUSSION 
 
 
The purpose of this study was to describe the quality of life in persons with end 
stage renal disease (ESRD) and examine factors which influence quality of life.  This 
chapter provides an interpretation of the findings as well as implications for nursing 
practice.  Recommendations for future research are suggested.   
Interpretation of Results 
Quality of life.  The mean quality of life for this sample was 21.14 (SD = 4.87).  
This finding was similar to other studies that have administered the Quality of Life Index- 
Dialysis (QLI-D) to persons with ESRD (Bihl et al., 1988; Ferrans & Powers, 1993; 
Greene, 2005; Jablonski, 2007; Laws et al., 2000).  These studies reported mean quality 
of life scores between 20.70 – 22.67.  Reported mean quality of life scores using the QLI 
for other populations include: (a) 17.4 (SD = 5.4) for persons living with chronic pain 
(Gerstle, All, & Wallace, 2001) (b) 19.4 (SD = 4.8) for persons with chronic lung disease 
(Verrill, Barton, Beasley, & Lippard, 2005), (c) 20.2 (SD = 4.6) for residents of nursing 
homes (Franks, 2004), (d) 21.0 (no SD reported) for persons with heart failure (Scott, 
Setter-Kline, & Britton, 2004), (e) 21.01 (SD = 4.27) for persons with spinal cord injuries 
(May & Warren, 2002), and (f) 22.74 (SD = 4.64) for women following coronary artery 
bypass graft (Penckofer, Ferrans, Fink, Barrett, & Holm, 2005).   The persons with ESRD 
in this study reported a quality of life better than all these populations, except for women 
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following heart surgery.  In fact, the mean was only slightly lower than a group of healthy 
persons (M = 21.9) using the general population version of the QLI (Ferrans, Cohen, & 
Smith, 1992).  These findings are contrary to a published study which reported a lower 
quality of life for persons with ESRD compared to persons with other chronic illnesses 
(Loos et al., 2003).  However, the researchers used the SF-36 to measure quality of life 
which may have measured health status rather than quality of life.   
The study findings suggest that persons with ESRD experience a relatively 
comparable quality of life.  Given their symptom burden and intensive dialysis regimen, 
such findings may seem curious.  However, it has been suggested that people adjust their 
life aspirations according to changes in life circumstances to maintain subjective well-
being (Ferrans & Powers, 1993).  The results of this study indirectly support such an 
adaptation.  The comparatively normal quality of life demonstrated in this study is a 
particularly encouraging finding because it suggests that the complex medical care 
required for this population provides a manageable quality of life.  In addition, it lends 
support to the large amounts of federal funding dedicated to the care of persons with 
ESRD.     
The health and functioning subscale of the QLI-D was the lowest rated subscale 
(M = 18.92, SD = 5.48).  It was over 2 points lower than the overall quality of life score.  
The family subscale was the highest of all the scales (M = 24.71, SD = 5.40).  These 
findings are similar to Ferrans and Powers’ (1993) study of 349 persons undergoing 
hemodialysis in Illinois in which the health and functioning subscale was the lowest 
subscale score (M = 18.64, SD = 5.71) and the family subscale was the highest (M = 
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25.25, SD = 5.07).  These findings support the heavy disease burden felt by persons with 
ESRD.  The large impact that health and functioning have on overall quality of life is the 
reason why many medical studies examining quality of life focus exclusively on disease 
burden.  Thus, the concept health-related quality of life might likely be measured by the 
health and functioning subscale of the QLI-D.   
The fact that the health and functioning subscale was the only subscale mean that 
was lower than the overall quality of life mean suggests that persons struggling with poor 
health and functioning may place greater importance on non-health factors to rebalance 
their quality of life.  According to Ferrans’ model (1996), socioeconomic, psychological/ 
spiritual, and family domains also contribute to overall quality of life.  The 
socioeconomic subscale was the next lowest subscale score in this study.  Almost a third 
of respondents reported that their annual household income was below the federal 
poverty level.  Given that socioeconomic factors are more difficult to change, especially 
when on a fixed income due to disability, the two remaining domains may be pivotal in 
contributing to overall quality of life.  Both the psychological/ spiritual and family 
subscales were rated high in this study.  These two domains may provide needed 
resources to cope with what would otherwise be a poorer quality of life.  Family and faith 
are more controllable factors than health and money.  Leaning on family and deepening 
one’s faith may be strategies employed by persons with ESRD to improve their overall 
quality of life. 
Health-related factors.  The nine health-related factors in the model significantly 
explained 59% of the variance in overall quality of life.  This finding lends support to the 
105                
 
important role that health-related factors play in quality of life.  However, only albumin, 
anxiety, depression, and general health perception were significant variables.   
Biological function.  Albumin and hemoglobin were the two biological factors 
selected for this study.  Albumin significantly contributed to quality of life when the 
independent variables were limited to health-related factors.  However, the significance 
level for albumin was borderline (p = 0.049) and when an outlier case was removed from 
the model, it ceased to be significant (p = 0.055).  Albumin was also not significant when 
the non-health-related variables were added to the model.  When examining bivariate 
correlations, albumin did not significantly correlate with overall quality of life (r = 
0.099).  These findings are similar to an earlier study that did not find a significant 
correlation between albumin and quality of life (Patel et al., 2002).  Studies that did find a 
significant relationship between albumin and quality of life (Lopes et al., 2007; Morsch et 
al., 2006) used a health status instrument, implying that albumin may impact health more 
than quality of life.  This may explain why albumin was only significant when the health-
related factors were examined.  One study using the QLI-D did find a significant 
relationship between albumin and overall quality of life, but only in severely 
malnourished persons (Laws et al., 2000).  Severely malnourished was defined using 
numerous objective and subjective assessment data, not just albumin levels.  In the 
present study, only 10% of the sample had a suboptimal albumin level and, more than 
likely, less than 10% would be classified as severely malnourished. Thus, albumin may 
not impact quality of life unless it reaches a critically low level.  The present study did 
not have enough critically low albumin levels to detect this relationship.  In fact, the 
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variable was negatively skewed requiring reflection and transformation before 
multivariate analyses. 
Hemoglobin also did not contribute to any of the regression models and did not 
significantly correlate with quality of life.  Other studies report similar results (Frank et 
al., 2003; Kalantar-Zadeh et al., 2001; Patel et al., 2002).  The studies which did find a 
significant correlation between hemoglobin and quality of life all used the SF-36 to 
measure quality of life and not a holistic quality of life scale (Baiardi et al., 2002; Lopes 
et al., 2007; Morsch et al., 2006).  Therefore, like albumin, hemoglobin may be a better 
determinant of health status than quality of life.  Although 43% of participants in this 
study had hemoglobin levels less than normal, the reason it did not significantly 
contribute to quality of life may be that their bodies have adapted to persistently low 
levels and thus, they do not experience symptoms that other persons with low 
hemoglobin levels might report.  In fact, in the present study, hemoglobin did not 
significantly correlate with fatigue (r = 0.107, p = 0.368), a common symptom of anemia.  
In addition, supplemental erythropoietin injections often assist dialysis patients in 
maintaining adequate hemoglobin levels.  Thus, persons on hemodialysis may be able to 
sustain normal hemoglobin levels or adapt to low levels, rendering it an insignificant 
factor in perceived quality of life.  As measures of biological function, the results of this 
study did not provide convincing support that either albumin or hemoglobin contributes 
to overall quality of life in persons with ESRD.  
Symptoms.  Dialysis symptoms, fatigue, anxiety, and depression were the 
symptom factors selected for this study.  Dialysis symptoms, as measured by the Dialysis 
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Symptom Index (DSI), were prevalent.  The DSI is comprised of 30 symptoms common 
to persons on dialysis.  Participants in this study reported from 2 – 29 symptoms, with a 
mean of 12.95 (SD = 5.93) symptoms.  This total number of symptoms is more than other 
studies which have reported 5.67 (Jablonski, 2007), 7.7 (Frank et al., 2003), and 9.8 
(Weisbord et al., 2005) total symptoms.  Because Weisbord used the DSI, only his results 
are truly comparable to this study.  The mean total DSI score for this study, which takes 
into account the severity of symptoms, was 41.85 (SD = 23.30).  The median value was 
38.  Although Weisbord (2005) did not report a mean, the median was 25.  Therefore, the 
participants in this study reported a greater number and higher severity of symptoms than 
have been previously reported.  Although the DSI correlated significantly with overall 
quality of life (r = 0.480, p < 0.001), it did not contribute significantly to overall quality 
of life in the total model.  Even when the anxiety and depression items were removed 
from the scale, the revised DSI still did not explain overall quality of life. These results 
are intriguing given the heavy symptom burden reported by participants.  Jablonski 
(2007) found that symptom scores, level of relief, and satisfaction with relief accounted 
for 28% of the variance in quality of life for persons with ESRD.   Since her model 
focused solely on symptoms, it may be that once a more complex model is created, 
symptoms no longer factor in as a significant determinant of overall quality of life. 
Fatigue was also prevalent in this study with over 91% of participants reporting 
some level of fatigue.  Other studies have reported fatigue prevalence between 77% and 
90% (Curtin, Bultman, et al., 2002; Frank et al., 2003; Jablonski, 2007; Merkus et al., 
1999; Weisbord et al., 2003).  Participants in this study reported a mean fatigue level of 
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43.27 (SD = 27.36) using a 100 mm visual analog scale (VAS).  This result is similar to 
another study with African American women on dialysis using a fatigue VAS in which 
the reported mean was 44.6 (SD = 33.1) (Williams et al., 2007).  Fatigue exhibited a low, 
negative correlation with quality of life (r = -0.282, p = 0.016), but did not contribute to 
the overall model.  Therefore, fatigue, as well as other common dialysis symptoms, does 
not seem to be a significant determinant of quality of life in a multi-factorial model.  It 
may be that persons with ESRD are able to adapt to their chronic symptom burden 
without it interfering significantly with their day-to-day quality of life.  Indeed, many of 
the symptoms are not acute in nature, but might be described by persons on dialysis as 
dull and nagging.  In addition, many symptoms might be adequately managed with 
medication or other interventions rendering them less of a factor in overall quality of life.   
Anxiety was also prevalent in the study sample.  Using a cut point of 8 on the 
anxiety subscale of the Hospital Anxiety and Depression Scale (HADS), 41% of 
participants were anxious.  This finding is much higher than a general population sample 
which reported anxiety prevalence at 13% (Cohen, Magai, Yaffee, & Walcott-Brown, 
2006) and slightly higher than other studies which have reported anxiety among persons 
with ESRD at 36% (Williams et al., 2007) and 38% (Murtagh et al., 2007).  The mean of 
6.52 (SD = 4.27) was somewhat lower than a study using the HADS with African 
American women on dialysis that reported a mean of 7.0 (SD = 3.26) (Williams et al., 
2007).  This difference in anxiety levels may be gender-related.  In the present study, men 
had a significantly lower anxiety level than women (t = 2.340, p = 0.022).  In a study of 
multiracial older adults, Cohen et al. (2006) also found the prevalence of anxiety to be 
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higher in women than men.  These gender differences may be due to higher reporting of 
anxiety symptoms by women, greater perceived stress, or other undetermined factors.                                                                                                                                                                                                                                                                                  
Unlike other symptoms examined in the study, anxiety was an important health-
related variable.  It correlated negatively with quality of life (r = -0.502, p < 0.001) and 
significantly contributed to every regression model, except one which included the health 
and functioning subscale of the QLI-D as the dependent variable.  The reason anxiety did 
not help explain health and functioning (p = 0.078) is unclear.  Interestingly, none of the 
ESRD quality of life studies reviewed included anxiety as an independent variable. 
Therefore, this finding may provide important insight into a vital determinant of quality 
of life for persons with ESRD.  The reason for its relative absence from the literature may 
be multi-factorial.  Given its prevalent nature, potential nonspecific symptoms, and the 
possible stigma associated with a psychological disorder, symptoms associated with 
anxiety might not be assessed by health care providers or reported by persons on dialysis.  
Therefore, practitioners might not adequately diagnose and treat anxiety.  Thus, the true 
prevalence of anxiety may be underestimated and not considered in quality of life studies.    
Depression was another important health-related variable in this study.  Using a 
cut-point of 8 on the HADS, 27% of participants were depressed.  This finding mirrored 
other studies which reported a 28% prevalence rate (Drayer et al., 2006; Murtagh et al., 
2007; Weisbord et al., 2005).  The mean of 5.36 (SD = 3.16) was identical to another 
study using the HADS in persons with ESRD in which the mean was 5.4 (SD = 3.52) 
(Williams et al., 2007).  Like anxiety, depression exhibited a negative correlation with 
quality of life (r = -0.576, p < 0.001) and significantly contributed to every regression 
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model, except one in which the family subscale of the QLI-D was the dependent variable.  
Other studies have also reported that depression is associated with a decreased quality of 
life (Drayer et al., 2006; Sesso et al., 2003; Walters et al., 2002).  Although not as 
prevalent as anxiety, depression appears to be a key determinant for overall quality of 
life.   
Functional status.  Function was measured with two instruments, the Inventory of 
Functional Status- Dialysis (IFS-D) and the Palliative Performance Scale (PPS).  The 
IFS-D is scored by averaging the responses to each instrument item yielding a 1-4 scale 
total, with a higher number indicating higher functioning.  The participants in this study 
had a mean IFS-D score of 3.00 (SD = 0.65).  This finding is quite different from a study 
by the instrument’s developer in which the mean IFS-D for 104 dialysis patients was 
reported to be between 1.29 and 1.37 (Thomas-Hawkins, 2000).  This difference may not 
be due to various populations included in the studies, but rather to validity issues with the 
tool.  The IFS-D lists 17 activities to which respondents self-report how independently 
they perform each activity (see Appendix E).  A key qualifier is that participants must 
report which activities they did do, not which activities they could do. This creates issues 
with some of the items that may be gender-biased.  For example, item number eight is 
“prepared meals.”  Some persons, especially older men, may never prepare meals 
because this activity is their spouse’s responsibility.  Functional capacity, or lack thereof, 
is not the issue.  Given this concern, the author of the IFS-D was contacted before data 
collection began and permission was granted to modify the instrument to include a “not 
applicable” response.  These questions were deleted from scale calculations, instead of 
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recording a response of 1 = did not do.  Since the scale total is the mean of all items, this 
modification resulted in higher scale totals.  In addition to gender-bias, other biases were 
noted.  For example, item number 13 is “attended church services.”  If the participant had 
never previously participated in faith-based activities, should the item be scored 1 = did 
not do, or marked as “not applicable” and deleted from calculations?  For this study, the 
later method was employed.  Without a “not applicable” alternative, the tool has serious 
validity issues and reported results using the original scoring should be interpreted with 
caution.  For example, the mean score reported above in the study by Thomas-Hawkins 
was 1.29 – 1.37.  This indicates the average response was somewhere between “did not 
do” and “did with a lot of help.”  This is not a logical ordinal progression and renders the 
results uninterpretable.  Even with the scale modification, the IFS-D did not yield 
significant results.  It did not correlate with overall quality of life nor contribute 
significantly to any of the regression models.  
Function was also measured with the PPS, a scale in which 100 = no evidence of 
disease and 0 = deceased.  The PPS has not been used with the renal population, 
however, the predecessor to this tool, the Karnofsky Performance Scale (KPS), has.  The 
improvements made to the KPS which resulted in the PPS include more specific 
descriptions of the five categories for classifying functional decline, as well as the 
deletion of requirements for hospitalization, as patients often have other non-hospital 
options at the end-of-life.  For this study, the mean PPS score was 75.89 (SD = 13.42).  In 
comparison to this study, KPS scores have shown similar results.  One study reported a 
mean KPS of 74.5 (SD = 16.6) (Patel et al., 2002), and another reported mean values 
112                
 
between 63.80 – 80.70 (Laws et al., 2000).  These similarities lend support to the use of 
the PPS in the renal population.  For this study, the PPS showed a low, positive 
correlation with overall quality of life (r = 0.256, p = 0.028). However, it was not a 
significant contributor to any of the regression models, including the analysis with the 
health and functioning subscale as the dependent variable.  This finding once again may 
be a result of adaptation by persons with ESRD to their chronic condition, and the 
relative value of functional status to overall quality of life.   
General health perception.  General health perception was measured with a single 
global question which measured perception of health on a scale from 1 = poor health, to 
10 = excellent health.  The mean score was 5.67 (SD = 1.83).  General health perception 
correlated higher with overall quality of life (r = 0.583, p < 0.001) than any of the other 
independent variables.  It was a significant contributor to all the regression models, 
except one in which the dependent variable was the family subscale of the QLI-D.  These 
results are similar to another study which also measured general health perception with a 
single 10-point Likert-type scale in two different dialysis populations (Bihl et al., 1988).  
The mean general health perception for persons on peritoneal dialysis was 5.5 (SD = 
1.99) and for persons on hemodialysis was 6.5 (SD = 1.94).  Correlations with quality of 
life (as measured by the QLI-D) were high for the peritoneal dialysis group (r = 0.71, p < 
0.001) and moderate for the hemodialysis group (r = 0.56, p < 0.02).  The significant 
results of general health perception in the present study, along with the findings reported 
by Bihl et al., suggest a meaningful relationship between general health perception and 
quality of life for persons with ESRD. 
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The significance of general health perception is an important finding.  When 
trying to evaluate quality of life, results from the current study indicate that it may be 
more important to understand the burden of disease from the person’s point of view 
rather than the practitioner’s.  During data collection, this researcher found it interesting 
that some persons with considerable debilitation perceived their health status as good to 
excellent, while some younger persons on dialysis who appeared more vigorous reported 
their health status as poor.  It may be that when evaluating one’s own health status, 
comparisons are made to persons of a similar age.  Older persons on dialysis may 
perceive that their non-dialysis contemporaries also experience multiple health problems, 
while younger persons observe few health-related issues in non-dialysis persons their 
own age.  Younger persons on dialysis may grieve their loss of health more intensely than 
older persons and may not have had enough time to normalize their dialysis lifestyle.   
Because ESRD is a chronic condition, many persons living with the disease may readjust 
their definition of health.  This “response shift” has been noted in persons as a way to 
cope with the effects of illness (Ferrans, 2005).  The medical regimen associated with 
renal failure, including diet, medications, and dialysis, may become the new health 
baseline.  Therefore, as long as no other illness processes are occurring, health is 
maintained according to the person’s adjusted internal standards.  
Characteristics of the individual.  Three characteristics of the individual were 
selected for inclusion in the study:  (a) age, (b) gender, and (c) race/ ethnicity.  None of 
these variables were significant in any of the regression models. According to the United 
States Renal Data System (2006), the mean age of all persons with ESRD in the United 
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States is 57.9 years, over half of the persons with ESRD are male (56%), 61% are White, 
and only 32% are African American.  Thus, the participants in this study were slightly 
younger and consisted of both more females and significantly more African Americans 
than the U.S. ESRD population.  
Age. Age was the only continuous variable in this category and ranged widely 
from 20 to 89 years, with a mean age of 56 years (SD = 15.8).  It was not a significant 
variable, which is similar to the results of a Brazilian study which examined age and 
quality of life in hemodialysis patients (Morsch et al., 2006).  However, other ESRD 
studies have found that increasing age is associated with a decreased quality of life 
(Baiardi et al., 2002; Ferrans & Powers, 1993; Frank et al., 2003; Lopes et al., 2007; 
Walters et al., 2002).  All these studies used the SF-36 or the kidney version of the SF-36 
to measure quality of life.  Therefore, the findings of these earlier studies may be best 
understood in terms of the relationship between increasing age and health status.  This 
relationship may also be illustrated in the present study.  Age significantly correlated with 
the two functional measures, which may be defined as a measure of health status:  (a) 
Inventory of Functional Status (r = -0.524, p < 0.001), and (b) Palliative Performance 
Scale (r = -0.407, p < 0.001).  These correlations may better corroborate the earlier 
findings using the SF-36.  
Greene (2005) found that younger dialysis patients had a significantly lower 
quality of life than older groups of patients.  In addition, Ferrans and Powers (1993) also 
found age to be positively correlated with quality of life.  However, for every 20-year 
increase in age, the QLI-D score only increased by one point.  Although age was 
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statistically significant, it did not seem to be a substantive variable.   For this study, age 
also had a positive although insignificant correlation with quality of life (r = 0.180, p = 
0.127) and was not a significant variable in any of the regression models.  Therefore, the 
results from this study indicate that age is not an important variable in understanding 
quality of life in persons with ESRD.  The reason for these findings may be that the 
debilitating effects of ESRD are experienced by all ages.   
Gender. Both genders were well represented in the study, with 55% of the 
participants in the study being female.  Like age, gender was not a significant variable in 
any of the regression models.  This finding is most comparable to Ferrans and Powers’ 
(1993) study which used the QLI-D with persons on hemodialysis.  A regression analysis 
using backward elimination found gender to be an insignificant variable.  Other studies 
using gender as an independent variable employed health status instruments to measure 
quality of life (Baiardi et al., 2002; Frank et al., 2003; Kalantar-Zadeh et al., 2001; Lopes 
et al., 2007; Walters et al., 2002), and therefore, the findings do not compare with the 
current study.  Consequently, gender does not appear to be a characteristic of the 
individual that impacts overall quality of life for persons with ESRD.  This result may be 
due to similarities between the genders for persons on dialysis.  In the present study, most 
did not work (84%), over half were not married (67%), and their health burdens with 
regards to ESRD were similar.  Thus, men and women on dialysis may not experience 
gender-specific distinctions which might impact quality of life differently. 
Race/ ethnicity.  The majority of participants in the study were African American 
(76%), which is somewhat higher than national proportions for ESRD in which African 
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Americans make up 61% of persons with kidney failure (USRDS, 2006).  However, age 
and gender adjusted rates for African Americans are over four times the rate for Whites 
(USRDS, 2006).  Like the other characteristics of the individual, race was not a 
significant variable in this study.   This finding corroborates Ferrans and Powers’ (1993) 
study which also found no racial differences in quality of life.  Their study had a reversed 
proportional sample in which only 33% of participants were African American and 61% 
were White.  Because Ferrans and Powers’ study took place in Illinois, whereas this study 
took place in North Carolina, the racial difference was most likely due to regional 
variations of the U.S. population.  Other studies which have examined the influence of 
gender on quality of life used health status instruments to measure quality of life making 
the results difficult to compare to the present study.  This study, along with Ferrans and 
Powers’ study, suggest that race/ ethnicity is not a factor in determining overall quality of 
life in persons with ESRD.  This finding is encouraging given the disproportional burden 
of ESRD in African Americans.   
Characteristics of the environment.  Three characteristics of the environment 
were selected for inclusion in the study:  (a) marital status, (b) socioeconomic status, and 
(c) time on dialysis.  Like characteristics of the individual, none of these variables were 
significant in any of the regression models. 
Marital status.  The majority of participants in the study were not married (67%).  
The finding that marital status was not a significant variable was an interesting outcome 
of this study.  However, it supported the work of Ferrans and Powers (1993) who also 
found no significant relationship between marital status and quality of life.  Interestingly, 
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a large percentage of the participants in this study had never been married (29%).  It may 
be that persons on hemodialysis receive support from other family members and friends, 
and that marriage is not necessary to receive the emotional and practical benefits that 
such a committed relationship may impart.  The family subscale of the QLI-D was the 
highest scoring subscale in this study, indicating that participants rated family 
relationships of high importance and were most satisfied with these relationships.   
Socioeconomic status.  Only 16% of participants in this study were employed, 
although 71% were less than 65 years old.  Many persons with ESRD do not work due to 
the weekly time commitment needed for dialysis which often is scheduled during regular 
work hours and because most also qualify for disability.  In the present study, almost one 
in three participants reported annual household incomes below federal poverty levels.  
Clearly, financial issues are associated with ESRD disability.  However, poverty level 
was not a significant variable in this study.  One reason for this finding may be that most 
persons on dialysis receive federally sponsored healthcare through the Medicare program.  
Thus, the participants in this study may not have been financially burdened by their 
healthcare.  Since many health-related variables were examined in this study, Medicare 
coverage may have mitigated some of the differences that might have been seen with 
quality of life.  In fact, over 87% of participants in this study reported that they were 
satisfied with their health care (item number two on the QLI-D).  Given that most 
participants had adequate healthcare coverage and were satisfied with it, poverty may not 
have been a factor in understanding health-related quality of life.  The fact that poverty 
level was not a significant variable in this study supports the findings of Ferrans and 
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Powers (1993) who found that annual income was not a significant variable in explaining 
overall quality of life.  It may be that persons who experience chronic health issues place 
less importance on material assets to maintain a sense of well-being.      
Time on dialysis.  The average time on dialysis for participants in this study was 
4.6 years.  For these participants, hemodialysis is a permanent way of life as most (58%) 
felt they were not likely to receive a kidney transplant.  Persons on dialysis are immersed 
in a highly technical, medicalized environment for over 12 hours per week that may serve 
as a constant reminder of infirmity.  However, in the present study, time on dialysis did 
not contribute significantly to overall quality of life.  Two other studies using the QLI-D 
found similar results (Ferrans & Powers, 1993; Jablonski, 2007), while two studies using 
health status instruments found that quality of life actually improved the longer one was 
on dialysis (Morsch et al., 2006; Walters et al., 2002).  These later studies may have been 
measuring an improvement in uremic symptoms rather than improvement in overall 
quality of life.  Reasons for the insignificant findings in this study may be due to the 
familiarity of the dialysis clinic and the rapport developed between participants and the 
dialysis staff and fellow patients.  Thus, instead of time on dialysis becoming a growing 
burden, time brings a sense of familiarity and even an extended social support system.  In 
addition, those who have been on dialysis for a longer period of time may have had more 
time to adjust psychologically to their new lifestyle. 
The revised Wilson and Cleary model of health-related quality of life.  The 
conceptual framework guiding this study was the revised Wilson and Cleary model of 
health-related quality of life (Ferrans et al., 2005).  Although the main antecedents to 
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overall quality of life in this model are health factors, the model also includes 
characteristics of the individual and characteristics of the environment which make it a 
holistic schema for understanding quality of life.  The framework provided guidance in 
selecting variables that may impact overall quality of life.  Together, the variables 
explained 61% of the variance in quality of life for persons with ESRD.  This is an 
important finding, as other ESRD quality of life studies have only reported R2 values 
between .03 (Sesso et al., 2003) and .28 (Jablonski, 2007).  These studies did not use as 
many variables as the present study.     
Implications for Nursing   
Quality of life is a complex construct with numerous antecedents.  It should be an 
important outcome measure for all persons with ESRD to ensure that the healthcare 
resources dedicated to this population are providing a sense of well-being and satisfaction 
with life.  Ascertaining quality of life requires input from the patient, and thus cannot be 
assessed independently by a clinician.  Indeed, “when determining quality of life of an 
individual, that person’s own judgment is the only one that is ethically justifiable” 
(Ferrans, 2005, p. 23).  Instruments are available that can assist in quantifying the 
assessment, such as the Quality of Life Index- Dialysis version. Although developed for 
research purposes, the QLI-D could be used to monitor individual changes in quality of 
life over time in a clinical setting, such as an outpatient dialysis center.  If used in this 
manner, a valid and reliable short version may need to be developed as the instrument has 
68 questions.  
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Symptom burden can be extreme in persons on dialysis.  Individuals should be 
assessed for symptoms every dialysis session and a plan of care communicated to all 
members of the healthcare team.  Those on dialysis need to be encouraged to discuss both 
physical and emotional symptoms and not accept them as a routine part of dialysis.  A 
team focus towards symptom management may offer a more comprehensive approach for 
alleviating physical symptoms and provide emotional support for dealing with the 
psychological burden associated with ESRD.   
Anxiety and depression are two symptoms that require special vigilance.  Their 
impact on overall quality of life may be quite significant, and thus, persons on dialysis 
should be intentionally screened for both disorders.  Assessing for symptoms associated 
with anxiety is especially important because anxiety may be more prevalent than 
depression in this population.  Persons with ESRD are at an added risk for being under- 
diagnosed for both anxiety and depression due to the nondescript symptoms, such as 
feeling tired and sleeping more, which may be accepted as normal consequences of 
dialysis.  In addition, patients may be embarrassed to discuss these feelings with their 
health care providers or consider their feelings trivial in relation to other physical 
problems.  However, emotional health appears to have a large influence on quality of life.  
A comfortable rapport should be developed with each person to allow expression of such 
feelings.  Pharmacological and non-pharmacological interventions should be explored in 
collaboration with the health care team until psychological needs are met.  Including the 
family in these discussions may help detect changes in behavior not reported by the 
person on dialysis and ensure appropriate support from family members.    
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Fatigue is highly prevalent in the dialysis population.  Besides having a physical 
impact, this debilitating symptom can also take an emotional toll.  Assessing individuals 
for their level of fatigue should be conducted on a frequent basis.  In addition, assisting 
individuals to identify their “normal” level of fatigue so that changes to this level can be 
recognized may ensure early detection of increased fatigue.  Examining factors that may 
contribute to the intensity, duration, timing, and character of fatigue may aid in 
developing interventions for lessening post-dialysis fatigue.  When fatigue cannot be 
adequately controlled, providing emotional support through active listening may provide 
some empathetic relief and build a trusting nurse-patient relationship. 
Determining general health perceptions may be an important way for nurses to 
gain insight into patients’ health experiences.  According to the revised Wilson and 
Cleary model (Ferrans et al., 2005), general health perception is highly subjective and 
takes into consideration biological factors, symptoms, functional status, as well as other 
undetermined factors.  Thus this model is a comprehensive, patient-centered measure that 
may provide a holistic view for nurses.  According to this study, a person’s perception of 
general health has significant bearing on overall quality of life, and therefore, it becomes 
a unique indicator of well-being.  Low perceptions of general health may warrant further 
exploration to determine underlying causes.  High perceptions of general health may 
provide additional validation that overall quality of life is acceptable.   
Family relationships were an important source of support for persons with ESRD 
in this study.  Including family members, as appropriate, in determining meaningful plans 
of care may enhance quality of life outcomes.  When important family members cannot 
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come to the dialysis center, finding alternative methods for communication, such as 
electronic mail, can ensure continued engagement of the family member in the person’s 
care.   
Of all the variables included in this study, three were particularly important in 
explaining overall quality of life: (a) anxiety, (b) depression, and (c) general health 
perception.  This finding speaks powerfully of the mind-body connection.  None of the 
biological, physiological, functional, or demographic variables adequately explained 
quality of life.  In the end, each person’s sense of internal emotional equilibrium 
ultimately determined overall quality of life.  This conclusion corroborates a meta-
analysis of 12 studies which found that mental health had a much greater impact on 
quality of life (which was distinguished from health status) than physical function (Smith, 
Avis, & Assmann, 1999).  This same study found that physical functioning had a greater 
impact on health status than overall quality of life.  The meta-analysis included five 
different chronic diseases, although ESRD was not represented.  These studies coupled 
with the results of the present study provide support for a holistic approach to quality of 
life, in that one’s quality of life cannot be determined by health status alone.  In addition, 
it helps to explain why quality of life studies in persons with ESRD have had mixed 
results.  Mainly, researchers have not made a distinction between quality of life and 
health status, when they are indeed different constructs which are influenced by different 
antecedents.   
Nursing has the potential to directly influence quality of life through interventions 
that may help patients rebalance their lives.  Innovative therapies which use holistic 
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approaches to healing may promote healthier adaptations to ESRD.  Examples of possible 
interventions include meditation, energy work, music therapy, support groups, and 
spiritual counseling. Exploration of these complementary approaches to care may reveal 
beneficial interventions that might improve overall quality of life.        
Recommendations for Future Research 
The term quality of life needs to be clearly defined in all future studies examining 
this variable.  The majority of quality of life studies in persons with ESRD have equated 
quality of life with health status and/ or physical function.  This physically-oriented 
approach to quality of life has been a confusing misuse of the term thereby yielding 
conflicting results.  Additional studies of quality of life in persons with ESRD that 
incorporate a holistic worldview are needed.  These future studies need to describe 
quality of life using a corresponding instrument that measures more than health status, 
such as the QLI-D.  Factors affecting quality of life from this holistic perspective need to 
continue to be identified.   
The present study used 15 variables representing various antecedents of quality of 
life according to the revised Wilson and Cleary conceptual framework for health-related 
quality of life (Ferrans et al., 2005).  Three variables were important determinants of 
overall quality of life: (a) anxiety, (b) depression, and (c) general health perception.  
Because only three were significant in the overall model, other independent variables 
which might further explain quality of life need to be identified and tested.   
None of the characteristics of the individual or characteristics of the environment 
selected for this study were significant.  The effect of age, however, is still not clear. 
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Further studies examining differences in younger and older persons and perceptions of 
quality of life may provide additional understanding.  Trending these perceptions over 
time may assist clinicians in understanding how persons cope with dialysis and chronicity 
as they age.  
While marital status was not a significant variable in determining quality of life, 
additional studies looking at the broader concept of social support, such as that provided 
by friends and family, may provide better information.  The role that the dialysis center 
milieu plays in social support also warrants further investigation.  Tailoring dialysis 
procedures to facilitate and encourage patient-to-patient interactions and patient-to-staff 
interactions may foster a greater perception of social support.  
Other individual and environmental characteristics need to be identified that may 
affect quality of life.  Given the results of this study, characteristics that influence 
psychological health may prove more helpful in explaining quality of life.  For example, 
important characteristics of the individual may be coping, spirituality, or role strain.  An 
influential characteristic of the environment may be place of dialysis.  For instance, 
persons on in-center dialysis may have a different quality of life than persons on home 
hemodialysis.  Further examination of these factors may yield greater insight into 
individual or environmental characteristics affecting quality of life. 
The convenience sample in this study was different from the U.S. ESRD 
population, thus limiting generalizability.  There were more African Americans and more 
women.  In addition, regional differences, such as religious preferences, may have 
affected perceptions of health and quality of life.  Studies are needed which use samples 
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consisting of more White, male participants and from other regions of the country.  Quota 
sampling would help to ensure a more representative ESRD sample. 
In addition to further exploration of characteristics of the individual and 
characteristics of the environment, health-related variables also need additional study.  
The role of albumin is not clear.  Further studies need to investigate the impact of 
albumin on overall quality of life, especially since this nutritional biomarker can often be 
modified through diet therapy.  Prealbumin levels also warrant additional study. 
Prealbumin may be a more precise indicator of malnutrition than albumin (Collins, 2001) 
and provide better information as a biological factor affecting quality of life.   
 General dialysis symptoms and fatigue were not significant variables in 
explaining overall quality of life.  Although quite prevalent within the sample, they did 
not factor in to the total model.  Further exploration of symptom burden and its impact on 
persons with ESRD is warranted.  Although most symptoms may be tolerable, there may 
be a threshold at which symptom load is unmanageable and impacts quality of life.  
Future researchers may want to categorize persons on dialysis into groups based on 
length of time on dialysis.  This methodology would assist in explaining adaptation to 
symptoms over time.   
Anxiety and depression consistently explained much variation in overall quality 
of life.  Anxiety is a new finding associated with quality of life studies in persons with 
ESRD.  Additional studies are needed to validate the effect of anxiety on quality of life.  
Depression is a well documented contributor to poor quality of life, and the current study 
lends further support.  Randomized controlled studies which provide non-
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pharmacological treatments for alleviating depression may provide important information 
on effective interventions in the ESRD population.    
Functional status was measured with two instruments, and neither scale was 
significant in explaining quality of life.  Validity issues with the Inventory of Functional 
Status- Dialysis need to be resolved and the revised scale needs to undergo subsequent 
reliability and validity testing.  No studies were found using the Palliative Performance 
Scale (PPS) with persons on dialysis.  Because this study yield similar PPS scores to 
other studies using the Karnofsky Performance Scale, continued testing of the PPS in the 
ESRD population is warranted.  The impact of functional status on quality of life remains 
unclear, and future studies are needed to further examine this relationship.  Stratifying 
participants into distinct functional categories may demonstrate differences in quality of 
life not clearly seen with a continuous measurement. 
General health perception appears to be an important factor in determining quality 
of life.  Further validation of this relationship is warranted through additional study.  
Differences in how persons with ESRD rate their health compared to how health care 
providers rate their patients’ health may provide interesting comparisons.  Determining 
reasons for varying health perceptions among similarly functioning individuals may 
provide insight into the psychological dimension of coping with chronic illness. 
An exciting avenue for future research is to examine the mind-body connection 
and its relationship to quality of life.  Further validation of this association is needed and 
potential interventions need to be designed for persons with ESRD.  The inclusion of 
complementary therapies during dialysis may offer additional defense against 
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psychological issues associated with chronic kidney disease, bolster general health 
perception, and positively impact quality of life.   
In contrast, examination of the impact of poor health perceptions and high levels 
of anxiety and depression on quality of life are needed.  Determining if one or a 
combination of these factors is most predictive of quality of life would provide additional 
information.  Studies which test interventions that may halt or reverse these factors and 
the effect of such interventions on quality of life are needed.  In addition, determining 
when a poor quality of life may not be reversible and if this condition is related to the end 
of life is crucial work.  Such determinations may assist health care providers in 
identification of the dying trajectory.  Once identified, interventions can be put into place, 
such as early hospice referrals, to promote a good death (Kring, 2006). 
The preceding paragraphs have discussed various portions of the revised Wilson 
and Cleary model (Ferrans et al., 2005). Each antecedent needs continued research to 
determine which factors can best determine overall quality of life.  In addition, the model 
as a whole needs further testing in the ESRD population, as well as other populations.  
No previous studies were found that used this conceptual framework to inform variable 
selection and guide statistical analyses.  Thus, further studies using this model are 
needed.  Formal testing using structural equation modeling (SEM) would elucidate the 
strength of the hypothesized relationships in the model (Munro, 2005).  Unlike path 
analysis, SEM allows for non-recursive pathways which may be important to understand 
how people adjust to chronic illness.  That is, persons with a debilitating illness may 
readjust their general health perception as a way to cope with changes in life 
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circumstances.  This adjusted perception may positively influence symptom experience, 
thus reversing the dominant causal flow of the model.  In addition to validating the 
theoretical constructs of the model, SEM can test the measurement model (Munro, 2005) 
by taking into consideration differences in error rates and determining how well the data 
fit the theoretical model. SEM also allows for testing with different populations to 
ascertain if the model performs equally well among various subgroups.  This 
determination may help explain differences in various illnesses and among various ESRD 
subpopulations.  Finally, by testing the strength of relationships, SEM may assist in 
creating a more parsimonious model by identifying weak associations for deletion.   
Based on the outcomes of this study, an additional category may need to be added 
to the model which includes psychological factors.  Although two psychological factors 
important in the present study (anxiety and depression) were incorporated as part of 
symptom factors, the overall model has a distinctly physiological bias.  Separating out 
psychological factors would give these factors greater prominence in explaining quality 
of life and encourage researchers to include them as variables in studies of quality of life.  
Further theoretical work would need to occur before hypothesizing where psychological 
factors would best fit in the model.   
Summary 
The purpose of this study was to describe the quality of life in persons with ESRD 
and examine factors which influence quality of life.  Participants reported a relatively 
good quality of life, considering their high symptom burden, decreased functional status, 
and moderate general health perception.  Anxiety, depression, and perception of health 
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had the greatest impact on overall quality of life, suggesting that psychological factors 
may better predict quality of life than physiological factors.  Therefore, incorporating 
psychosocial assessments into routine dialysis care and initiating interventions to 
rebalance and stabilize thought and mood may assist persons with ESRD to experience a 
higher quality of life.  Future studies should continue to identify variables that influence 
quality of life, determine interventions that enhance a person’s sense of well-being, as 
well as illuminate the relationship between quality of life and end of life.   
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APPENDIX A 
Dialysis Demographic Form 
 
 
Dialysis Demographic Form 
 
Part A: 
To be completed by PI or RA from the medical record. 
 
1.  Today’s date:  ____________ 
 
2.  Age:  __________ in years 
 
3.  Gender: 
   Male  (1) 
 Female (0) 
 
4.  Time on hemodialysis:  ___________ in months 
 Include all months on hemodialysis, including episodes separated by periods of 
peritoneal dialysis or transplantation. 
 
5.  Most recent serum albumin level:  _____________ grams/ liter   
  
Date of collection:  __________ 
 
6.  Most recent hemoglobin level:  ______________  grams/ dl 
 
Date of collection:  __________ 
 
7.  Field Notes.  Include questions that were problematic for the participant to answer, 
others issues that arose during data collection. 
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Dialysis Demographic Form 
 
Part B: 
To be asked of participants. 
 
1.  What race or ethnicity do you consider yourself? 
   African American/ Black  (1)   
 American Indian  (3) 
 Asian (4) 
 Caucasian/ White  (0) 
 White Hispanic  (2) 
 Non-white Hispanic (5) 
 Other:  ____________________________ (6) 
 Prefer not to answer (9) 
 
2.  What is your marital status? 
   Never married (1) 
 Married (0) 
 Divorced/ separated (2) 
 Widowed (3) 
 Prefer not to answer (9) 
 
3. If female, have you had a menstrual period in the past 12 months? 
 Yes (1) 
 No (includes hysterectomies) (0) 
 I do not know (8) 
 Prefer not to answer (9) 
 Not applicable, I am male (7) 
 
4. How likely are you to receive a kidney transplant? 
 Very likely (4) 
 Somewhat likely  (3) 
 Probably not likely  (2) 
 Not likely  (1) 
 I do not know  (8) 
 Prefer not to answer (9) 
 
 
 
Continue Next Page  
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5. Look at the Annual Family Income chart.  Is your household income more than the 
indicated amount for the number of people in your home? Include any wages, Social 
Security, pensions, and interests or dividends on savings and investments.  
 Yes, family income is equal to or more than the amount shown (0) 
 No, family income is not more than the amount shown (1) 
 Do not know (8) 
 Prefer not to answer (9) 
 
Number of People in Family 
Annual Family 
Income 
1 (only yourself) $10, 210 
2 13, 690 
3 17, 170 
4 20, 650 
5 24, 130 
6 27, 610 
7 31, 090 
8 34, 570 
For each additional person, add 3, 480 
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APPENDIX B 
 
Dialysis Symptom Index 
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APPENDIX C 
Hospital Anxiety and Depression Scale 
Choose one response from the four given.   You should give an immediate 
response and not think too long about the answers.   You should answer how it 
currently describes your feelings. 
 A I feel tense or 'wound up':  
 Most of the time 3
 A lot of the time 2
 
From time to time, 
occasionally
1
 Not at all 0
  
  
D
I still enjoy the things I used 
to enjoy:
 
 Definitely as much 0
 Not quite so much 1
 Only a little 2
 Hardly at all 3
  
 
A
I get a sort of frightened 
feeling as if something awful 
is about to happen:
 
 
Very definitely and quite 
badly
3
 Yes, but not too badly 2
 
A little, but it doesn't worry 
me
1
 Not at all 0
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D
I can laugh and see the funny 
side of things:
 
 As much as I always could 0
 Not quite so much now 1
 Definitely not so much now 2
 Not at all 3
  
A
Worrying thoughts go 
through my mind:
 
 A great deal of the time 3
 A lot of the time 2
 
From time to time, but not 
too often
1
 Only occasionally 0
  
D I feel cheerful:  
 Not at all 3
 Not often 2
 Sometimes 1
 Most of the time 0
  
A
I can sit at ease and feel 
relaxed:
 
 Definitely 0
 Usually 1
 Not Often 2
 Not at all 3
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 D I feel as if I am slowed down:  
 Nearly all the time 3
 Very often 2
 Sometimes 1
 Not at all 0
  
A
I get a sort of frightened 
feeling like 'butterflies' in 
the stomach:
 
 Not at all 0
 Occasionally 1
 Quite Often 2
 Very Often 3
  
D
I have lost interest in my 
appearance:
 
 Definitely 3
 
I don't take as much care as I 
should
2
 
I may not take quite as much 
care
1
 
I take just as much care as 
ever
0
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A
I feel restless as I have to be 
on the move:
 
 Very much indeed 3
 Quite a lot 2
 Not very much 1
 Not at all 0
  
D
I look forward with 
enjoyment to things:
 
 As much as I ever did 0
 Rather less than I used to 1
 Definitely less than I used to 2
 Hardly at all 3
  
A
I get sudden feelings of 
panic:
 
 Very often indeed 3
 Quite often 2
 Not very often 1
 Not at all 0
  
 
 
 
 
 
D
I can enjoy a good book or 
radio or TV program:
 
 Often 0
 Sometimes 1
 Not often 2
 Very seldom 3
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APPENDIX D 
 
Fatigue Visual Analog Scale 
 
 
 
During the past month, how much fatigue did you experience over 
the course of a typical week?   
 
Place an X on the line that shows how much fatigue you had. 
 
• If you had no fatigue, circle “no fatigue.” 
• If you had the worst fatigue imaginable, circle, “the 
worst fatigue imaginable.” 
 
 
 
 
 
 
 
 
 
 
 
        No fatigue      The worst  
fatigue imaginable 
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APPENDIX E 
 
Inventory of Functional Status- Dialysis 
 
 
INSTRUCTIONS:  Common activities are listed below. Please circle the answer that best 
describes the extent to which you actually performed these activities IN A WEEK 
TYPICAL FOR YOU IN THE PAST MONTH.  
 
  
IN A TYPICAL WEEK IN THE PAST MONTH 
  
 
Did not 
do 
Did 
with a  
lot of  
help 
Did,  
with 
some 
help 
 
 
Did by 
myself 
 
Not 
applicable 
for me 
 
1. Showered or bathed 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
2. Got dressed 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
3. Used the toilet 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
4. Did light housework  (For 
example, make the bed, pick up 
things) 
 
1 
 
2 
 
3 
 
4 
 
0 
 
5. Did moderate housework 
(For example, dust the furniture, 
vacuum, moderate home repairs) 
 
1 
 
2 
 
3 
 
4 
 
0 
 
6. Did the laundry 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
7. Washed the dishes 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
8.    Prepared meals 
 
 
1 
 
2 
 
3 
 
4 
 
0 
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Did not 
do 
Did  
with a  
lot of  
help 
Did 
with 
some 
help 
 
 
Did by 
myself 
 
Not 
applicable 
for me 
 
9. Took care of household 
business  (For example, pay the 
bills, do banking) 
 
1 
 
2 
 
3 
 
4 
 
0 
 
10. Did grocery shopping 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
11. Did shopping for things other 
than groceries 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
12. Ran errands  (For example, 
went to post office, went to 
cleaners) 
 
1 
 
2 
 
3 
 
4 
 
0 
 
13. Attended church services 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
14. Participated in church 
activities or groups 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
15. Participated in social clubs 
(For example, neighborhood 
groups, bowling leagues) 
 
1 
 
2 
 
3 
 
4 
 
0 
 
16. Participated in volunteer or 
service organizations 
 
 
1 
 
2 
 
3 
 
4 
 
0 
 
17. Went out socially with 
friends or relatives 
 
 
1 
 
2 
 
3 
 
4 
 
0 
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APPENDIX F 
 
Palliative Performance Scale and Reformatted Palliative Performance Scale 
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Reformatted Palliative Performance Scale 
 
1. Describe this person’s ability to walk: 
  Full.  Can walk without help when needed. 
  Reduced.  Can walk and get to a chair on own, but may need help 
every now and then. 
 Mainly sits/ lies down.  Does not walk much.  Usually up in a chair or 
lying down in bed. 
 Mainly in bed.  Rarely gets out of the bed.  Spends most of the time 
sitting or lying in bed. 
 Totally in the bed.  Never gets out of the bed.   
 
2. Describe this person’s activity and level of illness: 
 Normal activity & work.  No evidence of disease. 
 Normal activity and work.  Some evidence of disease.   
 Normal activity with effort.  Some evidence of disease.   
 Unable to do normal job and work activities.  Significant disease.   
 Unable to do hobby/ housework.  Significant disease.   
 Unable to do any work.  Extensive disease. 
 Unable to do most activity.  Extensive disease. 
 Unable to do any activity.  Extensive disease.   
 
3.  Self-care 
 Full.  Can take care of self without assistance. 
 Occasional assistance necessary.  Can take care of self, but 
occasionally needs assistance. 
 Considerable assistance required.  Can take care of self, but needs 
some help every day. 
 Mainly assistance.  Cannot take care of self without someone helping 
with most tasks. 
 Total care.  Depends completely on others to provide care. 
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4. Intake 
 Normal.  Eats usual diet and normal amounts of food.   
 Normal or reduced.  Eats pretty much the same, or sometimes not as 
much. 
 Minimal to sips.  Eat very little, and sometimes only drink fluids. 
 Mouth care only.  Does not eat or drink. 
 
5. Conscious level 
 Full.  Usually fully alert with no problems with thinking or 
remembering. 
 Full or Confusion.  Some confusion is present.   
 Full or Drowsy +/- confusion.  Often feels sleepy and not fully alert.  
May be confused.   
 Drowsy or Coma.  Is mostly drowsy, or rarely awake.   
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APPENDIX G 
 
General Health Perception 
 
 
How would you rate your health on a scale from 1 to 10,  
with 1= poor and 10= excellent?  Circle the number that best 
describes your health. 
 
1= poor health 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10= excellent health 
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APPENDIX H 
 
Quality of Life Index- Dialysis 
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